<SEC-DOCUMENT>0001193125-24-176824.txt : 20240710
<SEC-HEADER>0001193125-24-176824.hdr.sgml : 20240710
<ACCEPTANCE-DATETIME>20240709175354
ACCESSION NUMBER:		0001193125-24-176824
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240708
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240710
DATE AS OF CHANGE:		20240709

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LEGALZOOM.COM, INC.
		CENTRAL INDEX KEY:			0001286139
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				954752856
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35618
		FILM NUMBER:		241108271

	BUSINESS ADDRESS:	
		STREET 1:		954 VILLA STREET
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94041
		BUSINESS PHONE:		323-962-8600

	MAIL ADDRESS:	
		STREET 1:		954 VILLA STREET
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94041

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEGALZOOM COM INC
		DATE OF NAME CHANGE:	20040405
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d843790d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lz="http://leg.com/20240708" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-351">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-07-08_to_2024-07-08">0001286139</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="lz-20240708.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-07-08_to_2024-07-08"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001286139</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-08</xbrli:startDate> <xbrli:endDate>2024-07-08</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-362">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-07-08_to_2024-07-08" format="ixt:datemonthdayyearen" id="ixv-363">July&#160;8, 2024</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-364">LegalZoom.com, Inc.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-07-08_to_2024-07-08" format="ixt-sec:stateprovnameen" id="ixv-365">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-366">001-35618</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-367">95-4752856</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom" colspan="3"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-368">954 Villa Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-369">Mountain View</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-07-08_to_2024-07-08" format="ixt-sec:stateprovnameen" id="ixv-370">California</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-371">94041</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-372">(323)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-373">962-8600</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-07-08_to_2024-07-08" format="ixt-sec:boolballotbox" id="ixv-374">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-07-08_to_2024-07-08" format="ixt-sec:boolballotbox" id="ixv-375">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-07-08_to_2024-07-08" format="ixt-sec:boolballotbox" id="ixv-376">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-07-08_to_2024-07-08" format="ixt-sec:boolballotbox" id="ixv-377">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-378">Common Stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-379">LZ</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-07-08_to_2024-07-08" format="ixt-sec:exchnameen" id="ixv-380">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167; <span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-07-08_to_2024-07-08" format="ixt-sec:boolballotbox" id="ixv-381">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;2.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;9, 2024, LegalZoom.com, Inc. (the &#8220;Company&#8221;) issued a press release announcing the management transitions discussed below. In that press release, the Company reiterates its guidance for the quarter ended June&#160;30, 2024 and updates its guidance for the year ending December&#160;31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information included in Item 2.02 and Exhibit 99.1 shall not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered &#8220;filed&#8221; under the Exchange Act or incorporates it by reference into a filing under the Securities Act of 1933, as amended. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Chief Executive Officer Transition </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;8, 2024, the Company&#8217;s Board of the Directors (the &#8220;Board&#8221;) appointed Jeffrey Stibel, who currently serves as Chair of the Board, to serve as Chief Executive Officer of the Company, effective July&#160;9, 2024. Mr.&#160;Stibel will continue serving in his role as Chair of the Board. On July&#160;8, 2024, the Board determined to transition from Dan Wernikoff, effective July&#160;9, 2024, and Mr.&#160;Wernikoff resigned from the Board, effective July&#160;9, 2024. Subject to Mr.&#160;Wernikoff&#8217;s entrance into a separation agreement and release pursuant to his employment agreement, Mr.&#160;Wernikoff will be entitled to receive the severance benefits payable under Section&#160;4(a)(i) of his employment agreement. Mr.&#160;Wernikoff&#8217;s departure is not a result of a disagreement with the Company on any matter relating to the Company&#8217;s operations, policies or practices. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Biographical&#160;information for Mr.&#160;Stibel is available in the Company&#8217;s Definitive&#160;Proxy<span style="font-style:italic"> </span>Statement on Schedule 14A, filed with the Securities and Exchange Commission on April&#160;23, 2024, and such information is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with Mr.&#160;Stibel&#8217;s appointment as Chief Executive Officer, Mr.&#160;Stibel entered into an Employment Agreement with the Company, dated as of July&#160;9, 2024 (the &#8220;Employment Agreement&#8221;). The Employment Agreement has no specific term and provides that Mr.&#160;Stibel is <span style="white-space:nowrap">an&#160;at-will&#160;employee.</span> Pursuant to the terms of the Employment Agreement, Mr.&#160;Stibel (a)&#160;is entitled to an annual base salary of $575,000, (b) is eligible for a target annual performance bonus, currently equal to 100% of his annual base salary, based on the achievement of performance objectives determined by the Board, which bonus will be prorated for 2024, (c) is eligible to participate in the Company&#8217;s employee benefit plans, including medical, dental and vision insurance plans and 401(k) retirement benefits, and (d)&#160;is eligible for severance benefits, as described below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Employment Agreement also provides that Mr.&#160;Stibel will be granted equity awards as follows: (a)&#160;performance-based restricted stock units (&#8220;Special <span style="white-space:nowrap">Sign-On</span> PSUs&#8221;) with respect to a target amount of 2,675,159 shares of the Company&#8217;s common stock, (b)&#160;time-based restricted stock units (&#8220;2024 RSUs&#8221;) with respect to 535,031 shares of the Company&#8217;s common stock, and (c)&#160;performance-based restricted stock units (&#8220;2024 PSUs&#8221;) with respect to 802,547 shares of the Company&#8217;s common stock. The Special <span style="white-space:nowrap">Sign-On</span> PSUs have a five-year performance period (subject to a 44-day extension in certain circumstances) and will become eligible to vest upon the achievement of predetermined stock price targets. The Special <span style="white-space:nowrap">Sign-On</span> PSUs may vest, if at all, between 10% and 200% of the target grant date value based on the stock price targets achieved during the five-year performance period. Stock price targets will be deemed achieved based on a <span style="white-space:nowrap">45-trading</span> day weighted-average closing price. Upon the achievement of a stock price target, <span style="white-space:nowrap">one-half</span> of the eligible Special <span style="white-space:nowrap">Sign-On</span> PSUs will vest immediately and the other half will vest in one year, subject to Mr.&#160;Stibel&#8217;s continued employment as Chief Executive Officer through the vesting date. The 2024 RSUs will vest in substantially equal quarterly installments over a four-year period, subject to Mr.&#160;Stibel&#8217;s continuous service with the Company, with the vesting commencement date being August&#160;15, 2024 and the first vesting date being November&#160;15, 2024. The 2024 PSUs will be earned, if at all, subject to the Company&#8217;s achievement of Adjusted EBITDA for the year ending December&#160;31, 2024 relative to predetermined targets and will include a total stockholder return modifier for the Company&#8217;s relative performance against those companies in the Nasdaq Composite Index. If an Adjusted EBITDA target is achieved, <span style="white-space:nowrap">one-third</span> of the eligible 2024 PSUs will vest immediately and the remainder will vest in eight substantially equal quarterly installments, subject to Mr.&#160;Stibel&#8217;s continued employment as Chief Executive Officer through the vesting date, with the first vesting date being May&#160;15, 2025. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Employment Agreement, if Mr.&#160;Stibel is terminated by the Company without &#8220;cause&#8221; (excluding by reason of death or disability) or Mr.&#160;Stibel resigns for &#8220;good reason&#8221;, and such termination occurs outside of <span style="white-space:nowrap">the&#160;24-month&#160;period</span> following a &#8220;change in control&#8221; (each term as defined in the Employment Agreement), then Mr.&#160;Stibel will be eligible to receive the following severance benefits: (a)&#160;continued cash payments of his then-current annual base salary for 12 months; (b)&#160;reimbursement of the cost (to the same extent the Company was paying as of immediately before the termination date) for group health benefits continuation coverage under COBRA for up to 12 months; and (c)&#160;any Special <span style="white-space:nowrap">Sign-On</span> PSUs that have met the requisite stock price target(s) and that are subject to only time-based vesting and any 2024 RSUs, in each case that would have become vested within 12 months following such termination, will become immediately fully vested upon such termination. In addition, pursuant to the terms of the Employment Agreement, if, following the end of the year in which Mr.&#160;Stibel&#8217;s termination of employment occurs, the Company determines in good faith that the applicable performance bonus objectives and milestones for that year have been achieved, Mr.&#160;Stibel will be eligible to receive a performance bonus in the amount so determined by the Company, which will be prorated based on Mr.&#160;Stibel&#8217;s employment termination date. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Employment Agreement, if Mr.&#160;Stibel is terminated by the Company without &#8220;cause&#8221; (excluding by reason of death or disability) or Mr.&#160;Stibel resigns for &#8220;good reason&#8221; reason, and such termination occurs within 24 months following a &#8220;change in control&#8221;, then Mr.&#160;Stibel will be eligible to receive the following severance benefits: (a)&#160;a lump sum cash payment equal to the sum of (i)&#160;18 months of his then-current annual base salary plus (ii)&#160;a cash payment equal to 150% of the amount of his then-current target annual performance bonus for the fiscal year in which such termination occurs; (b)&#160;reimbursement of the cost (to the same extent the Company was paying as of immediately before the termination date) for group health benefits continuation coverage under COBRA for up to 18 months; (c)&#160;any unvested 2024 RSUs will become immediately fully vested upon such termination; and (d)&#160;any 2024 PSUs that have met the requisite Adjusted EBITDA target and that are subject to only time-based vesting will become immediately fully vested. In the event of a &#8220;change in control&#8221; prior to determining Adjusted EBITDA for 2024, <span style="white-space:nowrap">one-third</span> of the 2024 PSUs will become immediately fully vested assuming 100% of the target Adjusted EBITDA was achieved and the remainder will vest in substantially equal installments over the subsequent eight quarters, subject to Mr.&#160;Stibel continuing to be a service provider through the applicable vesting date. In the event of a change in control, the Special <span style="white-space:nowrap">Sign-On</span> PSUs will vest as of the change in control only to the extent that the <span style="white-space:nowrap">per-share</span> consideration received by stockholders in the change in control triggers achievement of a previously unmet stock price hurdle (without regard to the <span style="white-space:nowrap">45-trading</span> day requirement). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the Employment Agreement is attached as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> The foregoing description of the Employment Agreement is qualified in its entirety by reference to the full text of such agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no arrangements or understandings between Mr.&#160;Stibel and any other persons pursuant to which he was selected as an officer of the Company. There are also no family relationships between Mr.&#160;Stibel and any director or executive officer of the Company. Mr.&#160;Stibel has no direct or indirect material interest in any related party transaction required to be disclosed pursuant to Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Other Board Matters </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;8, 2024, the Board appointed John Murphy as Lead Independent Director of the Board, effective July&#160;9, 2024. The Board also removed Mr.&#160;Stibel as a member the Nominating and Corporate Governance Committee of the Board and appointed Sivan Whiteley as the Chair of the Nominating and Corporate Governance Committee, in each case, effective July&#160;9, 2024. Additionally, on July&#160;8, 2024, the size of the Board was reduced from six to five directors, effective July&#160;9, 2024. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Executive Retention Awards </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;8, 2024, the Compensation Committee of Board awarded time-based restricted stock units (&#8220;Retention RSUs&#8221;) with respect to 191,082 shares of the Company&#8217;s common stock, to each of Noel Watson, the Company&#8217;s Chief Financial Officer, Shrisha Radhakrishna, the Company&#8217;s Chief Technology Officer and Chief Product Officer and Nicole Miller, the Company&#8217;s Chief Legal Officer and Secretary. The Retention RSUs will vest in two substantially equal annual installments on July&#160;9, 2025 and July&#160;9, 2026, subject to continued service through the applicable vesting date. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d843790dex101.htm">Employment Agreement, by and between LegalZoom.com, Inc. and Jeffrey Stibel, dated July&#160;9, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d843790dex991.htm">Press Release of LegalZoom.com, Inc. dated July&#160;9, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="font-style:italic">The Company has omitted portions of the referenced exhibit pursuant to Item 601(b) of Regulation <span style="white-space:nowrap">S-K</span> because the information contained in such portions (a)</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;is not material and (b)</span><span style="font-style:italic"></span><span style="font-style:italic">&#160;is the type of information that the Company both customarily and actually treats as private and confidential.</span> </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">LegalZoom.com, Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: July&#160;9, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Noel Watson</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center"><span style="font-weight:bold">Noel Watson</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center"><span style="font-weight:bold">Chief Financial Officer</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center"><span style="font-style:italic">(Principal Financial and Accounting Officer)</span></td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d843790dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[The Company has omitted portions of this exhibit marked by [***] pursuant to Item 601(b) of Regulation
<FONT STYLE="white-space:nowrap">S-K</FONT> because the information contained in such portions (a)&nbsp;is not material and (b)&nbsp;is the type of information that the Company both customarily and actually treats as private and confidential.]
</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">July&nbsp;9, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Jeffrey Stibel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>delivered via
email </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dear Jeff: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On behalf of LegalZoom.com, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), I am pleased to provide you an offer
of employment with the Company pursuant to the terms and conditions set forth in this letter (this &#147;<U>Agreement</U>&#148;). All capitalized terms not otherwise defined shall have the definition and meaning provided in Section&nbsp;18. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1. <U>Title; Duties; Reporting</U>. You will serve as the Company&#146;s Chairman and Chief Executive Officer and as a member of the Board of
Directors of the Company (the &#147;<U>Board</U>&#148;) (subject to being nominated and <FONT STYLE="white-space:nowrap">re-elected</FONT> to the Board by Company stockholders) and shall report directly to the Board. You shall be a member of the
Company&#146;s senior management team and shall have such duties and responsibilities as shall be consistent with your position. You will also devote your full time, efforts, abilities, and energies to promote the general welfare and interests of
the Company and any related enterprises of the Company. You will loyally, conscientiously, and professionally do and perform all duties and responsibilities of your position, as well as any other duties and responsibilities as will be reasonably
assigned to you by the Company, consistent with your position and this Agreement. You will strictly adhere to and obey all Company rules, policies, procedures, regulations and guidelines including, but not limited to, those contained in the
Company&#146;s employee handbook, as well as any others that the Company may establish. You will strictly adhere to all applicable state and/or federal laws and/or regulations relating to your employment with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>No Conflicting Obligations</U>. By signing this Agreement, you confirm to the Company that you have no contractual
commitments or other legal obligations that would prohibit you from performing your duties for the Company or executing this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Outside Activities</U>. Notwithstanding the provisions of Section&nbsp;1, you may (i)&nbsp;serve as a director or
member of a committee or organization involving no actual or potential conflict of interest with the Company and its subsidiaries and affiliates; (ii)&nbsp;deliver lectures, fulfill speaking engagements, or perform academic pursuits;
(iii)&nbsp;engage in charitable and community activities; (iv)&nbsp;invest your personal assets in such form or manner that will not violate this Agreement or the Company&#146;s Insider Trading Policy as then in effect; and (v)&nbsp;otherwise engage
in the activities set forth on <U>Exhibit A</U>; provided, however, that the activities described in clauses (i), (ii), (iii), (iv), and (v)&nbsp;do not materially affect, interfere, or create an actual or potential conflict of interest with the
performance of your duties and obligations to the Company; further provided that at all times you comply with the Company&#146;s Code of Business Conduct and Ethics as then in effect and the Company&#146;s Corporate Governance Guidelines as then in
effect, including any overboarding policies set forth therein; and further provided that the Board must provide its advance written </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
consent with respect to the items referenced in clause (i)&nbsp;which consent the Board may not unreasonably withhold. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2. <U>Term</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>Term of Agreement</U>. This Agreement and your employment under the terms hereunder shall take effect on July&nbsp;9,
2024 (the &#147;<U>Effective Date</U>&#148;). The period from the Effective Date until the termination of your employment under this Agreement is hereinafter referred to as &#147;the term of this Agreement&#148; or &#147;the term hereof&#148; or
&#147;the Term.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Resignation</U>. Upon termination of your employment for any reason, you shall be deemed to
have immediately resigned from all positions as an employee, officer and/or director with the Company, and any of its affiliates, as of your last day of employment (the &#147;<U>Termination Date</U>&#148;), unless otherwise determined by the Board
in its sole discretion. This Agreement shall serve as notice of such resignations by you; provided, however, you agree to execute any documents that the Company may reasonably request evidencing such resignations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3. <U>Compensation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>Base Salary</U>. As of the Effective Date, your base salary shall be $575,000 per year, less applicable withholdings
and deductions, payable in accordance with the Company&#146;s standard payroll procedures. The base salary as determined herein and adjusted from time to time shall constitute the &#147;<U>Base Salary</U>&#148; for purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Performance Bonus</U>. During each fiscal year of the Company during the Term, you will be eligible to earn a cash
performance bonus (&#147;<U>Performance Bonus</U>&#148;) with a target amount of 100% of your Base Salary for the applicable fiscal year of the Company, which Performance Bonus shall be <FONT STYLE="white-space:nowrap">pro-rated</FONT> for 2024.
Your actual bonus for any fiscal year, if any, shall be based on the successful completion of the performance objectives that are prescribed and established between you and the Board. Except as set forth in Section&nbsp;4(a), to earn and receive any
Performance Bonus, you must remain employed by the Company through the date of each of the Performance Bonus payment(s) and the termination of your employment for any reason before such payment date means you will not receive such payment. The
Performance Bonus will be paid to you at the same time as other similarly-situated employees of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c)
<U>Company-Sponsored Benefits</U>. As a member of the senior management team of the Company, you will also be eligible to receive all Exempt-Level Benefits pursuant to the Company&#146;s standard benefit plans (as may be in effect from time to time)
that the Company generally provides to the other members of the senior management team, subject to the terms and conditions of such benefit plans. These currently include, without limitation, group health benefits, 401(k) retirement benefits,
business expense reimbursements, sick time and Company paid holidays. The Company may, in its sole discretion and from time to time, amend or eliminate any of these benefits. Notwithstanding the foregoing or any Company policy to the contrary, you
shall not accrue any paid time off (whether vacation or otherwise). Instead, you shall be permitted to take paid time off as you determine, subject to reasonable business needs. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) <U>Indemnification</U>. You shall be entitled to indemnification for
losses incurred in connection with your service as an officer or employee (including coverage under applicable insurance policies) on terms no less favorable than any other senior executives of the Company and as otherwise required by applicable
law. The indemnification described herein will be a continuing right to indemnification and will survive the termination of your employment or this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) <U>Equity Compensation</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) <U>Special <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSU Grant</U>. As soon as practicable following the Effective
Date, you will be granted restricted stock units (the &#147;<U>Special <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSUs</U>&#148;) with an approximate grant date value of $21,000,000 (the &#147;<U>Special
<FONT STYLE="white-space:nowrap">Sign-On</FONT> PSUs Grant Date Value</U>&#148;), subject to both (A)&nbsp;approval by the Board or the Compensation Committee of the Board (the &#147;<U>Compensation Committee</U>&#148;), and (B)&nbsp;you remaining
employed through the grant date of the Special <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSUs. Each Special <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSU will cover one share of the Company&#146;s common stock, and the aggregate number
of Special <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSUs will be calculated using the closing price of the Company&#146;s stock on July&nbsp;9, 2024, provided that any fractional Special <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSU
resulting from such division will be rounded down to the nearest whole Special <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSU. The Special <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSUs shall be granted under the Company&#146;s 2021
Equity Incentive Plan (the &#147;<U>2021 Plan</U>&#148;) and the Company&#146;s standard form of performance-based restricted stock unit agreement approved by the Board for use thereunder. The Special <FONT STYLE="white-space:nowrap">Sign-On</FONT>
PSUs shall vest as set forth on <U>Exhibit B</U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) <U>RSUs</U>. As soon as practicable following the Effective
Date, you will be granted restricted stock units (the &#147;<U>RSUs</U>&#148;) with an approximate grant date value of $4,200,000 (the &#147;<U>RSUs Grant Date Value</U>&#148;), subject to both (A)&nbsp;approval by the Board or the Compensation
Committee, and (B)&nbsp;you remaining employed through the grant date of the RSUs. Each RSU will cover one share of the Company&#146;s common stock, and the aggregate number of RSUs will be calculated using the closing price of the Company&#146;s
common stock on July&nbsp;9, 2024, provided that any fractional RSU resulting from such division will be rounded down to the nearest whole RSU. The RSUs shall be granted under the 2021 Plan and the Company&#146;s standard form of restricted stock
unit agreement approved by the Board for use thereunder. Subject to Section&nbsp;4(a) below and the terms of the 2021 Plan, <FONT STYLE="white-space:nowrap">one-sixteenth</FONT> (1/16th) of the RSUs shall vest on each of the sixteen
(16)&nbsp;Quarterly Vesting Dates (as defined below) following the Vesting Commencement Date (as defined below), subject to your Continuous Service (as defined in the 2021 Plan) on each vesting date. &#147;Vesting Commencement Date&#148; shall mean
the first Quarterly Vesting Date following the Effective Date, provided if the Effective Date occurs on a Quarterly Vesting Date, the Vesting Commencement Date shall mean the Effective Date. &#147;<U>Quarterly Vesting Dates</U>&#148; shall mean each
of February&nbsp;15, May&nbsp;15, August&nbsp;15, and November 15; provided, however, that to the extent any such date occurs on a weekend day or U.S. federal holiday, the Quarterly Vesting Date will be deemed to occur on the immediately following
day that is not a weekend day or U.S. federal holiday. Further details with respect to the RSUs are set forth on <U>Exhibit <FONT STYLE="white-space:nowrap">C-1</FONT></U> hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) <U>PSUs</U>. As soon as practicable following the Effective Date, you will be granted performance-based restricted stock
units (the &#147;<U>PSUs</U>&#148;) with an approximate grant date value of $6,300,000(the &#147;<U>PSUs Grant Date Value</U>&#148;), subject to both (A)&nbsp;approval by the Board or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the Compensation Committee, and (B)&nbsp;you remaining employed through the grant date of the PSUs. Each PSU will cover one share of the Company&#146;s common stock, and the aggregate number of
PSUs will be calculated using the closing price of the Company&#146;s common stock on July&nbsp;9, 2024, provided that any fractional PSU resulting from such division will be rounded down to the nearest whole PSU. The PSUs shall be granted under
2021 Plan and the Company&#146;s standard form of performance-based restricted stock unit agreement approved by the Board for use thereunder. Subject to Section&nbsp;4(a) below and the terms of the 2021 Plan, the PSUs shall vest as set forth on
<U>Exhibit <FONT STYLE="white-space:nowrap">C-2</FONT></U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4. <U>Termination of Employment</U>. Notwithstanding anything to the
contrary in this Agreement whether express or implied, your employment with the Company is <FONT STYLE="white-space:nowrap">at-will</FONT> and the Company may at any time terminate your employment with the Company and the Term, for any reason or no
reason, and with or without Cause, and you may resign from your employment with or without Good Reason and terminate the Term, in each case subject to the terms and provisions of this Agreement, and all as set forth in greater detail in this
Section&nbsp;4. If your employment terminates due to your resignation without Good Reason or by the Company for Cause, then you will not be eligible for any severance benefits. You shall receive payment from the Company of the Accrued Obligations
through the Termination Date upon the termination of your employment for any reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>Severance and Other
Termination Benefits</U>. Subject to Section&nbsp;4(a)(iv), if during the Term there is a Qualifying Termination or your employment with the Company terminates as a result of your death or Disability, then you shall be eligible to receive the
following payments and benefits (as applicable, the &#147;<U>Severance Benefits</U>&#148;): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) <U>Qualifying Termination
Outside of the Change in Control Period</U>. In the event you have a Qualifying Termination that occurs outside of the Change in Control Period, the Severance Benefits shall consist of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(A) cash severance payments of twelve (12)&nbsp;months&#146; continued Base Salary, subject to all applicable deductions and
withholdings, paid in accordance with the Company&#146;s standard payroll schedule over a period of twelve (12)&nbsp;months; provided, however (x)&nbsp;amounts shall accrue until the Release (as defined below) becomes fully and irrevocably
effective, and (y)&nbsp;in the event the Release Period spans two calendar years, no amount of such cash severance payments will be paid prior to January&nbsp;1 of the second calendar year; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(B) any earned and unpaid Performance Bonus for the calendar year ending prior to the date of your Qualifying Termination;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(C) if, following the end of the fiscal year of the Company in which your Qualifying Termination occurs, the Company
determines in good faith that the applicable Performance Bonus objectives and milestones for that fiscal year have been achieved, you will receive a Performance Bonus in the amount so determined by the Company, and
<FONT STYLE="white-space:nowrap">pro-rated</FONT> based on the date of your Qualifying Termination, payable to you on the earlier of (i)&nbsp;the date annual performance bonuses are paid to other similarly-situated employees of the Company and
(ii)&nbsp;March 15th of the calendar year next following the calendar year in which your Qualifying Termination occurs, subject to all applicable deductions and withholdings, provided that in the event the
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Release Period spans two calendar years, no amount of such cash severance payments will be paid prior to January&nbsp;1 of the second calendar year; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(D) to the extent permitted by applicable laws without incurring statutory penalties, the Company will reimburse the cost (to
the same extent that the Company was paying as of immediately before the Termination Date) for all group employee health benefits coverage continuation under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
(&#147;<U>COBRA</U>&#148;) to the same extent provided by the Company&#146;s group health plans immediately before the Termination Date (&#147;<U>COBRA Benefits</U>&#148;) for twelve (12)&nbsp;months after the Termination Date or until you become
eligible for group health insurance benefits from another employer, whichever occurs first, provided that you timely elect COBRA coverage. You agree (i)&nbsp;at any time either before or during the period of time you are receiving the COBRA Benefits
to inform the Company promptly in writing if you become eligible to receive group health coverage from another employer and to respond to any Company inquiries confirming that you did not become eligible for other coverage; and (ii)&nbsp;that you
may not increase the number of your designated dependents, if any, during this time unless you do so at your own expense. The period of such COBRA Benefits shall be considered part of your COBRA coverage entitlement period. Reimbursement for the
COBRA Benefits shall be provided to you within sixty (60)&nbsp;days of your submission of evidence of the premium payment, subject to such submission being delivered to the Company within sixty (60)&nbsp;days of your making the applicable payment;
and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(E) notwithstanding anything to the contrary set forth in the Company&#146;s 2021 Equity Incentive Plan or the
applicable award agreement, any of the RSUs granted pursuant to Section&nbsp;3(e)(ii) and any of the Special <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSUs granted pursuant to Section&nbsp;3(e)(i) that have met the requisite performance
hurdle(s) and that are subject only to time-based vesting, in each case that are held by you as of the date of your Qualifying Termination that would have become vested within the twelve (12)&nbsp;month period following your Qualifying Termination
had you remained employed will become immediately fully vested upon your Qualifying Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) <U>Qualifying
Termination During the Change in Control Period</U>. In the event you have a Qualifying Termination that occurs during the Change in Control Period, the Severance Benefits shall instead consist of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(A) a cash severance payment equal to the sum of: (i)&nbsp;eighteen (18) months&#146; of your Base Salary, plus (ii)&nbsp;any
earned and unpaid Performance Bonus for the calendar year ending prior to the date of your Qualifying Termination, plus (iii)&nbsp;a cash payment equal to 150% of your Performance Bonus at target level for the fiscal year of the Company in which
your Qualifying Termination occurs, subject to all applicable deductions and withholdings, paid as a <FONT STYLE="white-space:nowrap">one-time,</FONT> <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment on the first regularly-scheduled Company
payroll date falling after the date the Release becomes fully and irrevocably effective, provided that in the event the Release Period spans two calendar years, no amount of such cash severance payment will be paid prior to January&nbsp;1 of the
second calendar year; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(B) the COBRA Benefits, continuing for eighteen (18)&nbsp;months after the Termination Date or
until you become eligible for group health insurance benefits from another employer, whichever occurs first, and otherwise subject to the same terms and conditions set forth in Section&nbsp;4(a)(i)(C); and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(C) the special vesting set forth in Section (a)&nbsp;of <U>Exhibit <FONT
STYLE="white-space:nowrap">C-1</FONT></U> and Section II(b) of <U>Exhibit <FONT STYLE="white-space:nowrap">C-2</FONT></U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) <U>Termination of Employment due to Death or Disability</U>. In the event your employment with the Company terminates as
a result of your death or Disability, the Severance Benefits shall instead consist of the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(A) any earned and
unpaid Performance Bonus for the calendar year ending prior to the date of your termination; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(B) if, following the end
of the fiscal year of the Company in which your termination occurs, the Company determines in good faith that the applicable Performance Bonus objectives and milestones for that fiscal year have been achieved, you (or after your death, your estate)
will receive a Performance Bonus in the amount so determined by the Company, and <FONT STYLE="white-space:nowrap">pro-rated</FONT> based on the date of your termination, payable on the earlier of (i)&nbsp;the date annual performance bonuses are paid
to other similarly-situated employees of the Company and (ii)&nbsp;March 15th of the calendar year next following the calendar year in which your termination occurs, subject to all applicable deductions and withholdings, provided that in the event
the Release Period spans two calendar years, no amount of such cash severance payments will be paid prior to January&nbsp;1 of the second calendar year; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(C) the special vesting set forth in Section (b)&nbsp;of <U>Exhibit <FONT STYLE="white-space:nowrap">C-1</FONT></U> and
Section II(c) of <U>Exhibit <FONT STYLE="white-space:nowrap">C-2</FONT></U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iv) <U>Release of Claims</U>.
Notwithstanding anything to the contrary, in order to receive any Severance Benefits, you (or after your death, your estate) must timely execute and deliver (and not revoke) a separation agreement and general release of claims in favor of the
Company, any affiliates or related entities, and their employees and affiliates, substantially in the form and content attached as <U>Exhibit D</U> hereto (the &#147;<U>Release</U>&#148;), within the time period specified in the release, but in any
event such release must become effective by its terms by no later than the 55th day following the Termination Date (such time period, extended by an additional 7 days, the &#147;<U>Release Period</U>&#148;). For the avoidance of doubt, in no event
shall you be eligible to receive Severance Benefits pursuant to both Section&nbsp;4(a)(i) and Section&nbsp;4(a)(ii) and you are not eligible to receive any Severance Benefits in the event your employment is terminated as a result of your death or
Disability other than as provided for in Section&nbsp;4(a)(iii). You shall receive payment or benefits from the Company of the Accrued Obligations, as applicable, regardless of whether a separation agreement and general release of claims in the form
and content attached as <U>Exhibit D</U> hereto is executed and timely provided to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Termination for
Cause</U>. The Company may terminate your employment and the Term at any time for Cause. In the event you are provided written notice of a potential termination for Cause (subject to any cure period, as set forth in the definition of Cause), your
right to exercise any equity compensation award (and the vesting or settlement of any equity compensation award) shall automatically be suspended during the cure period (if any). Upon the termination of your employment for Cause, you shall not be
entitled to exercise any outstanding equity compensation award whatsoever and all of your outstanding equity compensation awards (both vested and unvested) shall automatically terminate without consideration. Any determination by the Company
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
with respect to the foregoing shall be final, conclusive and binding on all interested parties. Any termination for Cause will not limit any other right or remedy the Company may have under this
Agreement or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) <U>Termination without Cause</U>. The Company shall have the unilateral right to terminate
your employment and the Term at any time without Cause, and without notice, in the Company&#146;s sole and absolute discretion. Any such termination without Cause shall not constitute a breach of any term of this Agreement, express or implied, or a
wrongful deprivation of your office or position. If the Company terminates your employment and the Term without Cause, it shall be treated as a Qualifying Termination and the Company shall have no obligation to you, except to pay you (or cause to
occur, if applicable) the amounts (and actions) set forth in Section&nbsp;4(a) above in accordance with the terms thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) <U>Termination due to Death</U>. Your employment and the Term will be automatically terminated on the date of your death.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) <U>Termination due to Disability</U>. If you are subject to a Disability, and if within thirty (30)&nbsp;days after
written notice is provided to you by the Company you shall not have returned to fully perform your duties, your employment and the Term, upon a second written notice from the Company, will be terminated for Disability as of the date set forth in
such second written notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) <U>Resignation for Good Reason</U>. You may terminate your employment and the Term at any
time for Good Reason; provided that you provide the Company with written notice within thirty (30)&nbsp;days of the date of the initial existence of the purported Good Reason event and such notice must describe in detail the basis and underlying
facts supporting your belief that a Good Reason event has occurred (the &#147;<U>Good Reason Notice</U>&#148;). Failure to timely provide such Good Reason Notice to the Company means that you will be deemed to have consented to and irrevocably
waived that particular potential Good Reason event. After its receipt of the Good Reason Notice, the Company shall then have sixty (60)&nbsp;days to cure or remedy the alleged Good Reason event. If the Company does cure or remedy the alleged Good
Reason event during such sixty (60)&nbsp;day period then the Good Reason event will be deemed to have not occurred. If the Company does not cure or remedy the Good Reason event during such sixty (60)&nbsp;day period then your employment with the
Company shall be automatically terminated for Good Reason as of the day following the expiration of the sixty (60)&nbsp;day cure/remedy period. If you terminate your employment for Good Reason in accordance with the provisions of this
Section&nbsp;4(f), it shall be treated as a Qualifying Termination and the Company shall pay you (or cause to occur, if applicable) the amounts (and actions) set forth in Section&nbsp;4(a) above in accordance with the terms thereof and any related
provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) <U>Resignation without Good Reason</U>. You may terminate your employment and the Term
at any time for no reason, or for any reason that does not otherwise constitute Good Reason, in your sole and absolute discretion, but only if you provide written notice to the Company at least fifteen (15)&nbsp;days prior to the effective date of
your intended resignation date (and such notice must specify the effective date of your resignation of employment). In the event you so terminate your employment without Good Reason, you shall only be entitled to receive (subject to Section&nbsp;14
below) the Accrued Obligations through the Termination Date and neither you nor the Company shall have any further obligations to the other except as set forth in Sections 6 through 15. The </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Company is not obligated to employ your services (nor compensate you) for any length of time beyond the fifteen (15)&nbsp;day period commencing from the date of your written notice to the Company
of your intended resignation. Further, the Company is not obligated to actually utilize your services at any time during such period commencing from the date of your written notice to the Company of your intended resignation through the Termination
Date, and the Company may prevent you from accessing any of the Company&#146;s premises or resources during such period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">5. <U>Golden
Parachute Excise Tax</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) In the event that it shall be determined that any payment, distribution or other action by
the Company to or for your benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, (a &#147;<U>Payment</U>&#148;)) would be subject to any excise tax (an &#147;<U>Excise Tax</U>&#148;)
imposed by Section&nbsp;4999 of the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), and if, immediately prior to the Relevant 280G Event (as defined below), the Payments are eligible for the shareholder approval exemption
under Section&nbsp;280G(b)(5)(B) of the Code, and (ii)&nbsp;Company shareholders, as of the Effective Date, control sufficient voting power, as of immediately prior to the Relevant 280G Event, to approve the Payments so as to exempt the Payments
from Excise Taxes (the two foregoing conditions, the &#147;<U>Shareholder Approval Conditions</U>&#148;) then: (i)&nbsp;the Company shall submit the Payments for shareholder approval to the extent necessary for no Excise Tax to be due and
(ii)&nbsp;you shall execute such releases or other documents necessary to seek to obtain the requisite shareholder approval in a manner satisfying Section&nbsp;280G(b)(5)(B) of the Code. For purposes of this Section&nbsp;5, &#147;Relevant 280G
Event&#148; means the relevant change in ownership or effective control, or change in the ownership of a substantial portion of the assets, of a corporation (all within the meaning of Section&nbsp;280G of the Code), that will or may result in
Payments becoming subject to the Excise Tax. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) In the event that at least one of the Shareholder Approval Conditions is
not satisfied or if the Shareholder Approval Conditions are inapplicable, then the Payments shall be payable as to such less amount which would result in no portion of such payments or distributions being subject to the Excise Tax; provided,
however, that no such reduction shall be made if the net after-tax amount (after taking into account federal, state, local or other income, employment and excise taxes) to which you would otherwise be entitled without such reduction would be greater
than the net <FONT STYLE="white-space:nowrap">after-tax</FONT> amount (after taking into account federal, state, local or other income, employment and excise taxes) to you resulting from the receipt of such payments and benefits with such reduction.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) If a reduction in the Payments is necessary so that no Payment is subject to the Excise Tax, the reduction shall
occur in the following order: (1)&nbsp;reduction of cash payments for which the full amount is treated as a parachute payment; (2)&nbsp;cancellation of accelerated vesting (or, if necessary, payment) of cash awards for which the full amount is not
treated as a parachute payment; (3)&nbsp;cancellation of any accelerated vesting of equity compensation awards; and (4)&nbsp;reduction of any continued employee benefits. In selecting the equity compensation awards (if any) for which vesting will be
reduced under clause (3)&nbsp;of the preceding sentence, awards shall be selected in a manner that maximizes the <FONT STYLE="white-space:nowrap">after-tax</FONT> aggregate amount of the Payments provided to you; provided, that, if (and only if)
necessary in order to avoid the imposition of an additional tax under Section&nbsp;409A (as defined below), awards instead shall be selected in the reverse order of the date of grant. For the avoidance of doubt, for purposes of measuring an equity
compensation </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
award&#146;s value to you, such award&#146;s value shall equal the then aggregate fair market value of the vested shares underlying the award less any aggregate exercise price less applicable
taxes. Also, if two or more equity compensation awards are granted on the same date, each award will be reduced on a <FONT STYLE="white-space:nowrap">pro-rata</FONT> basis. In no event shall you have any discretion with respect to the ordering of
payment reductions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) In no event will the Company be required to gross up any payment or benefit to you to avoid the
effects of the Excise Tax or to pay any regular or excise taxes arising from the application of the Excise Tax. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) All
mathematical determinations and all determinations of whether any of the Payments are &#147;parachute payments&#148; (within the meaning of Section&nbsp;280G) that are required to be made under this Section&nbsp;5, shall be made by a nationally
recognized independent audit firm, law firm or other advisor selected by the Company (the &#147;Advisors&#148;), who shall provide their determination, together with detailed supporting calculations regarding the amount of any relevant matters, both
to the Company and to you. Such determination shall be made by the Advisors using reasonable good faith interpretations of the Code. Any determination by the Advisors shall be binding upon the Company and you, absent manifest error. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6. <U>Expense Reimbursement</U>. You shall be reimbursed for all documented reasonable business expenses that are incurred in the ordinary
course of business upon the properly completed and timely submission of requisite forms and receipts to the Company in accordance with the Company&#146;s expense reimbursement policy as in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">7. <U>Confidential Information</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) As an employee of the Company, you will have access to certain confidential information of the Company and you may, during
the course of your employment or thereafter, develop certain information or inventions which will be the property of the Company. You acknowledge that you will be making use of, acquiring and/or adding to confidential information. The confidential
information is and will remain the sole and exclusive property of the Company. You will not at any time use, divulge, disclose or communicate, either directly or indirectly, in any manner whatsoever, any confidential information to any person or
business entity, or remove from the premises of the Company any confidential information in whatever form, unless required by you to perform the essential functions of your position with the Company while employed by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) In consideration of, and as a condition to, your continued employment with the Company, and as an essential inducement to
the Company to enter into this Agreement, this Agreement is expressly subject to your continued compliance with the Confidential Information and Employee Invention Assignment Agreement (the &#147;<U>Confidentiality Agreement</U>&#148;) between you
and the Company attached hereto as <U>Exhibit E</U> (but with such changes as the Company may determine are necessary to reflect changes in applicable law). You will fully comply with all obligations under the Confidentiality Agreement and further
agree that the provisions of such agreement shall survive any termination or expiration of this Agreement or termination of your employment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">8. <U>Covenants</U>. You and the Company (as applicable) agree to timely and fully comply
with all of the covenants set forth in this Section&nbsp;8 and further understand and agree that such covenants (in addition to Sections 5 and 9 through 15) shall survive any termination of your employment and termination or expiration of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) <U>Return of Company Property</U>. On your Termination Date, or at any other time as required by the
Company, you will immediately surrender to the Company all Company property, including, but not limited to, Confidential Information (as such term is defined in the Confidentiality Agreement), keys, key cards, computers, telephones, pagers, credit
cards, automobiles, equipment, and/or other similar property of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) <U>Mutual Nondisparagement</U>. You will
not, at any time during the period of your employment with the Company and for a period of two (2)&nbsp;years thereafter, make (or direct anyone else to make) any disparaging statements (oral or written) about the Company, or any of its affiliated
entities, officers, directors, employees, stockholders, representatives or agents, or any of the Company&#146;s products or services or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">work-in-progress,</FONT></FONT> that are
harmful to their businesses, business reputations or personal reputations. The Company will not in any authorized corporate communication, and will instruct the members of the Board to not, during the period of your employment with the Company and
for a period of two (2)&nbsp;years thereafter, make (or direct anyone else to make) any disparaging statements (oral or written) about you, that are harmful to your businesses, business reputation or personal reputation. Notwithstanding this
Section&nbsp;8(b), nothing herein shall prohibit any party from providing truthful testimony in connection with a governmental investigation or legal proceeding or from reporting a suspected violation of law, or from rebutting false or misleading
comments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) <U><FONT STYLE="white-space:nowrap">Non-Solicit</FONT></U>. During your employment with the Company and for
twelve (12)&nbsp;months after your Termination Date, but only to the extent permitted by applicable law, you shall not, directly or indirectly, either as an individual or as an employee, agent, consultant, advisor, independent contractor, general
partner, officer, director, stockholder, investor, lender, or in any other capacity whatsoever, of any person, firm, corporation or partnership: (i)&nbsp;solicit, induce, recruit or encourage any of the Company&#146;s employees or consultants to
terminate their relationship with the Company, or (ii)&nbsp;attempt to solicit, induce, recruit, or encourage any of the Company&#146;s employees or consultants to terminate their relationship with the Company, or (iii)&nbsp;attempt to solicit,
induce, recruit, encourage or take away employees or consultants of the Company; provided, however, that you may respond to requests for references regarding any person to the extent that you did not actively encourage or initiate the underlying
action or subject matter to which the reference relates. A general advertisement for employment not targeted at any specific individual shall not constitute a violation of this Section&nbsp;8(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) <U><FONT STYLE="white-space:nowrap">Non-Disclosure</FONT></U>. Notwithstanding any requirement that the Company may have
to publicly disclose the terms of this Agreement (and its exhibits) pursuant to applicable law or regulations, you agree to use reasonable efforts to maintain in confidence the existence of this Agreement, the contents and terms of this Agreement,
and the consideration for this Agreement (hereinafter collectively referred to as &#147;<U>Agreement Information</U>&#148;). You also agree to take every reasonable precaution to prevent disclosure of any Agreement Information to third parties,
except for disclosures required by law or absolutely necessary with respect to your immediate family </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
members or personal advisors who shall also agree to maintain the confidentiality of the Agreement Information. Nothing herein shall prevent any disclosure by you as required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) <U>Cooperation</U>. You agree that, upon the Company&#146;s request, during the five (5)&nbsp;years immediately following
your termination of employment with the Company you shall reasonably cooperate with the Company (and be available as reasonably necessary) after the Termination Date in connection with any matters involving events that occurred during your period of
employment with the Company. When making requests for you to assist with matters involving events that occurred during your period of employment with the Company, the Company agrees to reasonably accommodate your schedule. If the Company requests
more than five (5)&nbsp;hours of your time in any calendar month, the Company will compensate you for your time in excess of that number of hours on reasonable mutually agreeable terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) <U>Amounts Due</U>. You will fully pay off any outstanding amounts owed to the Company no later than their applicable due
date or within thirty (30)&nbsp;days of the Termination Date (if no other due date has previously been established). Within thirty (30)&nbsp;days of the Termination Date, you will submit any outstanding business expense reports to the Company for
business expenses incurred prior to the Termination Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g) <U>Company Resources</U>. As of the Termination Date, or at
any other time as required by the Company, you will no longer represent that you are an officer, director or employee of the Company or any Company affiliate and you will immediately discontinue using the Company mailing address, telephone,
facsimile machines, voice mail and <FONT STYLE="white-space:nowrap">e-mail.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) <U>Representations</U>. You
represent that you have not entered into any agreements, understandings, or arrangements with any person or entity that you would breach as a result of, or that would in any way preclude or prohibit you from entering into, this Agreement with the
Company or performing any of the duties and responsibilities provided for in this Agreement. You represent that you do not possess any confidential, proprietary business information belonging to any other entity, and will not use any confidential,
proprietary business information belonging to any other entity in connection with your employment with the Company. You represent that you are not resigning employment or relocating any residence in reliance on any promise or representation by the
Company regarding the kind, character, or existence of such work, or the length of time such work will last, or the compensation therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) <U>Clawback Policy</U>. The Company may (i)&nbsp;cause the cancellation of any equity or cash compensation,
(ii)&nbsp;require reimbursement of any of your equity or cash compensation and (iii)&nbsp;effect any other right of recoupment of equity or other compensation provided under this Agreement or otherwise, in each case to the extent required under
applicable law or pursuant to the requirements of a stock exchange applicable to the Company. In addition, you understand and agree that incentive compensation paid to you (including, without limitation, bonuses and equity compensation) shall be
subject to recoupment in the event that, subsequent to payment, the Board reasonably determines that required performance criteria was, in fact, not satisfied (for example, due to a subsequent financial restatement). Without limiting the generality
of the foregoing, you acknowledge and agree that you will be subject to the Company&#146;s clawback policy as it may be amended from time to time. A current copy of our clawback policy is included as Exhibit 97.1 to
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023, filed with the Securities and Exchange Commission on February&nbsp;29, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(j) <U>Violations</U>. You acknowledge that (i)&nbsp;upon a violation of any of the covenants contained in this
Section&nbsp;8, or (ii)&nbsp;if the Company is terminating your employment for Cause as provided under this Agreement, the Company would sustain irreparable harm as a result and that the Company would not have entered into this Agreement without
such restrictions, and, therefore, you agree that in addition to any other remedies which the Company may have, the Company shall be entitled, without bond of any kind, to seek equitable relief including specific performance and injunctions (without
posting of bond) restraining you from committing or continuing any such violation. Moreover, the Company will be entitled to an accounting of profits, compensation, remuneration or other benefits received by you, in addition to any other
contractual, legal or equitable rights, damages or remedies available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">9. <U>Entire Agreement</U>. This Agreement and its attachments,
the Confidentiality Agreement, and any other agreements referenced herein, as amended or superseded from time to time, contain the entire agreement between you and the Company regarding their terms and supersede any and all prior written or oral
understandings between you and the Company regarding their terms (the &#147;<U>Prior Agreements</U>&#148;). Except as otherwise provided herein, this Agreement may not be amended or modified except in a writing, executed by you and a duly authorized
officer of the Company other than yourself. This Agreement may be executed by facsimile or email signatures and in counterparts, each of which shall constitute an original, and all of which shall constitute one and the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">10. <U>Choice of Law; Severability; Waiver</U>. This Agreement will be governed by the laws of the State of California, United States, without
reference to the conflict of law provisions thereof. If any provision of this Agreement, or portion thereof, shall be held invalid or unenforceable by a court of competent jurisdiction, such invalidity or unenforceability shall attach only to such
provision or portion thereof, and shall not in any manner affect or render invalid or unenforceable any other provision, or portion thereof, of this Agreement. No breach of any provision hereof can be waived unless in writing. Waiver of any one
breach of any provision hereof will not be deemed to be a waiver of any other breach of the same or any other provision of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">11. <U>Successors and Assigns</U>. The Company may assign this Agreement to any successor (whether by amalgamation, merger, consolidation,
sale of assets, purchase or otherwise) to all or substantially all of the equity, assets or business of the Company, and this Agreement will be binding upon and inure to the benefit of such successors and assigns, including any successor entity. You
may not assign this Agreement or your obligations hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">12. <U>Notice</U>. Any and all notices required or permitted to be given to
you or the Company pursuant to the provisions of this Agreement will be in writing, and will be effective and deemed to provide such party sufficient notice hereunder on the earliest of the following: (i)&nbsp;at the time of personal delivery, if
delivery is in person; (ii)&nbsp;one (1) business day after deposit with an express overnight courier for United States deliveries, or two (2)&nbsp;business days after such deposit for deliveries outside of the United States; (iii)&nbsp;three (3)
business days after deposit in the United States mail by certified mail (return receipt requested) for United States deliveries. All notices that the Company is required to or may desire to give you that are not delivered personally will be sent
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
with postage and/or other charges prepaid and properly addressed to you at your home address of record with the Company, or at such other address as you may from time to time designate by one of
the indicated means of notice herein. All notices that you are required to or may desire to give to the Company that are not delivered personally will be sent with postage and/or other charges prepaid and properly addressed to the Company&#146;s
General Counsel at its principal office, or at such other office as the Company may from time to time designate by one of the indicated means of notice herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">13. <U>Withholding and Taxes</U>. The Company shall have the right to withhold and deduct from any payment provided for hereunder or under any
other Company plan or agreement any federal, state, local or foreign taxes of any kind required by law to be withheld with respect to any such payment. The Company (including without limitation members of the Board) shall not be liable to you or
other persons as to any unexpected or adverse tax consequence realized by you and you shall be solely responsible for the timely payment of all taxes arising from this Agreement that are imposed on you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">14. <U>Section</U><U></U><U>&nbsp;409A</U>. This Agreement is intended to be exempt from or comply with the requirements of Code
Section&nbsp;409A (&#147;<U>Section</U><U></U><U>&nbsp;409A</U>&#148;). In the event this Agreement or any benefit paid to you hereunder is deemed to be subject to Section&nbsp;409A, you consent to the Company adopting such conforming amendments as
the Company deems necessary, in good faith and in its reasonable discretion, to comply with Section&nbsp;409A and avoid the imposition of taxes under Section&nbsp;409A. Each payment made pursuant to any provision of this Agreement, including under
Section&nbsp;4(a), shall be considered a separate payment and not one of a series of payments for purposes of Section&nbsp;409A. Notwithstanding anything to the contrary herein, except to the extent any expense, reimbursement or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefit provided pursuant to this Agreement does not constitute a &#147;deferral of compensation&#148; within the meaning of Section&nbsp;409A: (A)&nbsp;the amount of expenses eligible for reimbursement or <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits provided to you during any calendar year will not affect the amount of expenses eligible for reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided to you in any other
calendar year; (B)&nbsp;the reimbursements for expenses for which you are entitled to be reimbursed shall be made on or before the last day of the calendar year following the calendar year in which the applicable expense is incurred; and
(C)&nbsp;the right to payment or reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits hereunder may not be liquidated or exchanged for any other benefit. While it is intended that all payments and benefits provided under this
Agreement to you will be exempt from or comply with Section&nbsp;409A, the Company makes no representation or covenant to ensure that the payments under this Agreement are exempt from or compliant with Section&nbsp;409A. The Company will have no
liability to you or any other party if a payment or benefit under this Agreement is challenged by any taxing authority or is ultimately determined not to be exempt or compliant. You further understand and agree that you will be entirely responsible
for any and all taxes on any benefits payable to you as a result of this Agreement. In addition, if upon your Separation from Service, you are then a &#147;specified employee&#148; (as defined in Section&nbsp;409A), then notwithstanding anything to
the contrary in this Agreement, and solely to the extent necessary to comply with Section&nbsp;409A and avoid the imposition of taxes under Section&nbsp;409A, the Company shall defer payment of &#147;nonqualified deferred compensation&#148; subject
to Section&nbsp;409A payable as a result of and within six (6)&nbsp;months following such Separation from Service under this Agreement until the earlier of (i)&nbsp;the first business day of the seventh month following your Separation from Service,
or (ii)&nbsp;ten (10) days after the Company receives written notification of your death. Any such delayed payments shall be made without interest. Furthermore, for purposes of compliance </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
with Section&nbsp;409A, references to &#147;terminate,&#148; &#147;termination&#148; or the like shall be interpreted to mean your Separation from Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">15. <U>Offset</U>. Notwithstanding anything to the contrary in this Agreement, any severance or other payments or benefits made to you under
this Agreement may be reduced, in the Company&#146;s discretion, by any amounts you owe to the Company or as will be needed to satisfy any future <FONT STYLE="white-space:nowrap">co-payments</FONT> you would need to make for continuing post-
termination benefits; <U>provided</U>, <U>however</U>, that any such offsets do not violate Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">16. <U>Voluntary
Agreement</U>. You acknowledge that you have been advised to review this Agreement with your own legal counsel and other advisors of your choosing and that prior to entering into this Agreement, you have had the opportunity to review this Agreement
with your attorney and other advisors and have not asked (or relied upon) the Company or its counsel to represent you or your counsel in this matter. You further represent that you have carefully read and understand the scope and effect of the
provisions of this Agreement and that you are fully aware of the legal and binding effect of this Agreement. This Agreement is executed voluntarily by you and without any duress or undue influence on the part or behalf of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">17. <U>Professional Fees</U>. The Company will reimburse you, upon presentation of documentation, for the reasonable fees and expenses
incurred by your legal and financial advisors in connection with the review and negotiation of this Agreement and other agreements or documents related to the Company&#146;s offer of employment, up to a maximum of $75,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">18. <U>Definitions</U>. The following definitions shall apply for purposes of this Agreement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) &#147;<U>Accrued Obligations</U>&#148; shall mean the sum of (i)&nbsp;any portion of your accrued but unpaid Base Salary
through the Termination Date; (ii)&nbsp;subject to Section&nbsp;14, any compensation previously earned but deferred by you (together with any interest or earnings thereon) that has not yet been paid and that is not otherwise to be paid at a later
date pursuant to any deferred compensation arrangement of the Company to which you are a party, if any; (iii)&nbsp;your accrued but unpaid vacation pay through the Termination Date; (iv)&nbsp;any reimbursements that you are entitled to receive under
Section&nbsp;6 of the Agreement or otherwise; and (v)&nbsp;any vested benefits or amounts that you are otherwise entitled to receive under any plan, policy, practice or program of or any other contract or agreement with the Company in accordance
with the terms thereof (other than any such plan, policy, practice or program of the Company that provides benefits in the nature of severance or continuation pay). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) &#147;<U>Cause</U>&#148; shall mean that one or more of the following has occurred: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) you have been convicted of, plead guilty or no contest to, or entered into a plea agreement with respect to (x)&nbsp;any
felony (under the laws of the United States, any relevant state, or the equivalent of a felony in any international jurisdiction in which the Company does business) or (y)&nbsp;any crime involving dishonesty or moral turpitude; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) you have engaged in (A)&nbsp;any willful misconduct (including any violation of federal securities laws) or gross
negligence, or (B)&nbsp;any act of dishonesty, violence or threat of </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
violence, in each case with respect to this clause (B), that would reasonably be expected to result in a material injury to the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) you have breached a material written policy of the Company or the rules of any governmental or regulatory body
applicable to the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iv) you (y)&nbsp;have willfully failed to materially perform or uphold your duties under this
Agreement and/or (z)&nbsp;willfully fail to comply with lawful directives of the Board (including, without limitation, failure to comply with business travel requirements set by the Board); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(v) you have materially breached this Agreement or any other material contract to which you and the Company are parties </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><U>provided</U> that, with respect to Sections 18(b)(iii), 18(b)(iv), and 18(b)(v) and if the event giving rise to the claim of Cause is
curable, the Company provides you written notice of the event within thirty (30)&nbsp;days of the Company learning of the occurrence of such event, and such Cause event remains uncured thirty (30)&nbsp;days after the Company has provided such
written notice; <U>provided further</U> that any termination of your employment for &#147;Cause&#148; with respect to Sections 18(b)(iii), 18(b)(iv), or 18(b)(v) occurs no later than thirty (30)&nbsp;days following the expiration of such cure
period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) &#147;<U>Change in Control</U>&#148; shall mean any one or more of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(i) any &#147;person&#148; (as such term is used in Section&nbsp;13(d) and 14(d) of the Securities Exchange Act of 1934, as
amended (the &#147;<U>Exchange Act</U>&#148;)), other than a trustee or other fiduciary holding securities of the Company under an employee benefit plan of the Company, becomes the &#147;beneficial owner&#148; (as defined in Rule <FONT
STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of (A)&nbsp;the outstanding shares of common stock of the Company or
(B)&nbsp;the combined voting power of the Company&#146;s then-outstanding securities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(ii) the Company is party to a
merger or consolidation, or series of related transactions, which results in the voting securities of the Company outstanding immediately prior thereto failing to continue to represent (either by remaining outstanding or by being converted into
voting securities of the surviving entity) at least fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iii) the sale or disposition of all or substantially all of the Company&#146;s assets (or consummation of any transaction, or
series of related transactions, having similar effect); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(iv) the dissolution or liquidation of the Company; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(v) any transaction or series of related transactions that has the substantial effect of any one or more of the foregoing.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, to the extent required for compliance with Section&nbsp;409A,
in no event will a Change in Control be deemed to have occurred if such transaction is not also a &#147;change in the ownership or effective control of&#148; the Company or &#147;a change in the ownership of a substantial portion of the assets
of&#148; the Company, as determined under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5).</FONT> In addition, a transfer of ownership or control of the Company between and among affiliated funds of Francisco
Partners shall not be a Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) &#147;<U>Change in Control Period</U>&#148; shall mean the period
commencing on the Change in Control and ending 24 months following a Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(e) &#147;<U>Disability</U>&#148;
shall mean your medically determinable physical or mental incapacitation such that for a continuous period of not less than twelve (12)&nbsp;months, you are unable to engage in any substantial gainful activity or which can be expected to result in
death. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(f) &#147;<U>Good Reason</U>&#148; shall mean any one or more of the following that occur without your consent:
(i)&nbsp;a material diminution in your Base Salary or target bonus opportunity, except for reductions that are comparable to reductions generally applicable to similarly situated executives of the Company (ii)&nbsp;a material diminution in your job
duties, responsibilities and/or authority as the Company&#146;s Chief Executive Officer, or (iii)&nbsp;a material change in the geographic location at which you must perform your services to the Company, which shall be defined to be a relocation of
your principal workplace to a new location that is more than fifty (50)&nbsp;miles away from your then-current principal workplace. Notwithstanding the foregoing, a diminution in your responsibilities as a director of the Board, including any
reduction, sharing or relinquishment of your title and/or role as a director, shall not constitute Good Reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(g)
&#147;<U>Qualifying Termination</U>&#148; shall mean your employment is terminated without Cause (excluding by reason of your death or Disability) by the Company or by you for Good Reason (each, a Qualifying Termination). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(h) &#147;<U>Separation from Service</U>&#148; has the meaning set forth in Treasury Regulations Section&nbsp;1.409A- 1
(h)(1). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">19. <U>Exhibits</U>. All Exhibits attached to this Agreement shall be incorporated herein by this reference as though fully set
forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A duplicate original of this Agreement is enclosed for your records. If you decide to accept the terms of
this Agreement, please sign the enclosed copy of this Agreement in the spaces indicated and return it to me. Your signature will acknowledge that you have read and understood and agreed to the terms and conditions of this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In witness whereof, the parties have each executed this Agreement as of the
dates indicated below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>LegalZoom.com, Inc.</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Nicole Miller</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Its: Chief Legal Officer and Secretary</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dated: July&nbsp;9, 2024</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Jeffrey Stibel</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Jeffrey Stibel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dated: July&nbsp;9, 2024</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Employment Agreement]</I> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OUTSIDE ACTIVITIES </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">[***] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT B </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SPECIAL <FONT STYLE="white-space:nowrap">SIGN-ON</FONT> PSU VESTING SCHEDULE FOR GRANT NOTICE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><U>Performance-Based Vesting Criteria</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Shares covered by the <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSU will become eligible to vest based upon achievement
of the following performance criteria (the &#147;<B><I>Performance Goals</I></B>&#148;) in the following manner: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The <FONT
STYLE="white-space:nowrap">Sign-On</FONT> PSU will become eligible to vest upon certification by the Compensation Committee (&#147;<B><I>Certification</I></B>&#148;) that, during the five (5)&nbsp;year period following the date of grant (such
period, as it may be truncated or extended in accordance with the provisions below, the &#147;<B><I>Performance Period</I></B>&#148;), the volume weighted average closing price per share, over a consecutive forty-five (45)&nbsp;trading day period
(the &#147;<B><I>Average Closing Price</I></B>&#148;) equals or exceeds [***]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, if, as of the earlier of
(1)&nbsp;fifth anniversary of the date of grant, and (2)&nbsp;a Good Leaver Termination (as defined below), the shares are trading above a previously-unachieved stock price target, the Performance Period will be extended by 44 days and the <FONT
STYLE="white-space:nowrap">Sign-On</FONT> PSUs will be eligible for Certification with respect to stock performance during such period. Any <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSUs that are not Certified based on the stock price during
that time period shall be forfeited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><U>Employment-Based Vesting Criteria</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition to the performance-based vesting requirements set forth above, the shares covered by the <FONT
STYLE="white-space:nowrap">Sign-On</FONT> PSU also are subject to the following <FONT STYLE="white-space:nowrap">employment-based</FONT> vesting requirements. The number of shares subject to the <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSU
that become eligible to vest based on achievement of the above Performance Goals, as certified by the Compensation Committee in its sole discretion, will be referred to as &#147;<B><I>Eligible Shares</I></B>.&#148; 50% of the Eligible Shares will
vest upon Certification, and the remainder of the Eligible Shares will vest on the first anniversary of the date of Certification, provided that the Participant remains in continuous employment as Chief Executive Officer through the applicable
vesting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Notwithstanding the foregoing, upon termination of continuous employment as Chief Executive Officer
(a)&nbsp;by the Company without Cause; (b)&nbsp;by the Participant for Good Reason, or (c)&nbsp;by reason of the Participant&#146;s death or Disability (each as defined in the employment agreement between the Participant and the Company (the
&#147;<B><I>Employment Agreement</I></B>&#148;) and, any such event, a &#147;Good Leaver Termination&#148;), the vesting of any Eligible Shares that are then subject only to time-based vesting (or that become Certified in the 44 day period described
above) shall accelerate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><U>Change in Control</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If, during the Performance Period, a Change in Control (as defined in the Employment Agreement) occurs, then the Performance
Period will be shortened such that the Performance Period will end as of the Change in Control and, to the extent that any of the Performance Goals are achieved based on the value of the <FONT STYLE="white-space:nowrap">per-share</FONT>
consideration received by the Company&#146;s </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
stockholders in connection with the Change in Control (the &#147;<B><I><FONT STYLE="white-space:nowrap">Per-Share</FONT> Consideration</I></B>&#148;) (and, for the avoidance of doubt, in lieu of
and without regard to any forty-five (45)&nbsp;weighted trading day closing price average otherwise required with respect to determining the achievement of Performance Goals not in connection with a Change in Control), such Performance Goal will be
deemed achieved under the <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSU, as determined by the Compensation Committee in its sole discretion, and the applicable shares subject to the <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSU as a
result of such Performance Goal achievement will become Eligible Shares and will vest as of the Change in Control. Any shares subject to the <FONT STYLE="white-space:nowrap">Sign-On</FONT> PSU that have not become Eligible Shares prior to or upon
the Change in Control will be forfeited automatically. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT <FONT STYLE="white-space:nowrap">C-1</FONT> </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SERVICE-BASED RSU VESTING SCHEDULE FOR GRANT NOTICE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vesting Commencement Date</B>: August&nbsp;15, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Vesting Schedule</B>: Except as otherwise provided herein, the RSU Award will vest in 16 substantially equal quarterly installments from
the Vesting Commencement Date. Only whole Restricted Stock Units shall vest. Fractional Restricted Stock Units that otherwise would vest shall accumulate and shall vest as to one whole Restricted Stock Unit when such accumulated, but unvested,
fractional Restricted Stock Units equal or exceed one. Notwithstanding the foregoing, except as set forth below, vesting shall terminate upon the Participant&#146;s termination of Continuous Service, as described in Section&nbsp;6(l) of the
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Special Vesting</B>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(a) Notwithstanding any other provision contained in this Grant Notice or the Agreement, in the event the Participant has a Qualifying
Termination that occurs during the Change in Control Period, there shall be immediate vesting acceleration of one hundred percent (100%) of the restricted stock units subject to this RSU Award to the extent outstanding and unvested as of the date of
the Participant&#146;s Qualifying Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(b) Notwithstanding any other provision contained in this Grant Notice or the Agreement,
in the event the Participant&#146;s employment with the Company terminates as a result of the Participant&#146;s death or Disability, the restricted stock units subject to this RSU Award, to the extent unvested and outstanding immediately prior to
such termination of the Participant&#146;s employment, shall immediately become fully vested. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(c) Notwithstanding any other provision
contained in this Grant Notice or the Agreement, in the event the Participant has a Qualifying Termination that occurs outside the Change in Control Period, the restricted stock units subject to this RSU Award that are held by the Participant as of
the date of such Qualifying Termination and that would have become vested within the twelve (12)&nbsp;month period following such Qualifying Termination had the Participant remained employed shall become immediately fully vested upon such Qualifying
Termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(d) Capitalized terms used but not defined in the foregoing paragraphs shall have the meaning set forth in the written
employment agreement entered into between the Company and the Participant. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT <FONT STYLE="white-space:nowrap">C-2</FONT> </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PSU VESTING SCHEDULE FOR GRANT NOTICE </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Vesting and Issuance Schedule: </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Following the conclusion of the period from January&nbsp;1, 2024 to December&nbsp;31, 2024 (the
&#147;<B><I>Performance Period</I></B>&#148;), the Compensation Committee shall meet, either at its regularly scheduled meeting or at a special meeting of the Compensation Committee called prior to the Company&#146;s release of its earnings for the
year ended December&nbsp;31, 2024, to certify achievement of the performance measures set forth on Annex A attached hereto and the resulting number of restricted stock units to be issued to you (the &#147;<B><I>Eligible Stock Units</I></B>&#148;
and, the date of such certification, the &#147;<B><I>Certification Date</I></B>&#148;). Any fractional Eligible Stock Unit that becomes earned shall be rounded down to the nearest whole share. Any PSUs that the Compensation Committee determines
shall not be Eligible Stock Units for the Performance Period in accordance with the Grant Notice and Annex A shall terminate and be forfeited as of the last day of the Performance Period, and you shall have no further rights with respect to any such
PSUs that are determined not to be Eligible Stock Units. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Subject to the terms and conditions of the PSU Agreement, the number of PSUs that the Compensation Committee
has determined are Eligible Stock Units in accordance with paragraph (a)&nbsp;of this Grant Notice and Annex A hereto, if any, shall vest and become <FONT STYLE="white-space:nowrap">non-forfeitable</FONT> as follows:
<FONT STYLE="white-space:nowrap">(i)&nbsp;one-third</FONT> of such Eligible Stock Units shall vest immediately on the Certification Date and (ii)&nbsp;the remaining Eligible Stock Units shall vest in eight (8)&nbsp;substantially equal quarterly
installments, with the first quarterly installment to vest on May&nbsp;15, 2025. Notwithstanding the foregoing, and except as set forth below, vesting shall terminate upon the Participant&#146;s termination of Continuous Service, as described in
Section&nbsp;6(l) of the Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">One share of Common Stock will be issued for each Eligible Stock Unit that vests at the time set forth in
paragraph (b), subject to Section&nbsp;5 of the Agreement. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify"><B>Special Vesting: </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding any other provision contained in this Grant Notice or the Agreement, in the event of a
Change of Control prior to the Certification Date, the PSUs shall convert to Eligible Stock Units in an amount equal to the number of Eligible Stock Units to be received assuming achievement of Adjusted EBITDA of $[***] (100% of target), without
regard to the TSR Modifier (as defined on Annex A); provided, further, that <FONT STYLE="white-space:nowrap">one-third</FONT> of such Eligible Stock Units shall vest on the date of the Change of Control and the remaining Eligible Stock Units shall
vest in eight substantially equal installments on a quarterly basis following such date, subject to the Participant continuing to be a service provider through each such date and accelerated if the acquirer does not assume the PSU Award in an
economically equivalent manner. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding any other provision contained in this Grant Notice or the Agreement, in the event the
Participant has a Qualifying Termination that occurs during the Change in Control Period, there shall be immediate vesting acceleration of one hundred percent (100%) of the Eligible Stock Units subject to this PSU Award to the extent outstanding and
unvested as of the date of the Participant&#146;s Qualifying Termination. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Notwithstanding any other provision contained in this Grant Notice or the Agreement, in the event the
Participant&#146;s employment with the Company terminates as a result of the Participant&#146;s death or Disability, the Eligible Stock Units subject to this PSU Award, to the extent unvested and outstanding immediately prior to such termination of
the Participant&#146;s employment, shall immediately become fully vested. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">Capitalized terms used but not defined in this paragraph shall have the meaning set forth in the written
employment agreement entered into between the Company and the Participant. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>NNEX</SMALL> <SMALL>A</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PSU PERFORMANCE CRITERIA </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Adjusted
EBITDA </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">[***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Relative Total
Stockholder Return (&#147;TSR&#148;) Modifier </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">[***] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT D </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMS AND </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COVENANT NOT TO SUE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SEPARATION AGREEMENT AND RELEASE OF ALL CLAIMS AND COVENANT </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>NOT TO SUE </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This Separation Agreement and Release of All Claims and Covenant Not to Sue (&#147;<U>Release</U>&#148;) is made pursuant to
the Employment Agreement (&#147;<U>Employment Agreement</U>&#148;) entered into by and between Jeffrey Stibel (&#147;<U>Employee</U>&#148;) and LegalZoom.com, Inc., a Delaware corporation (&#147;<U>Company</U>&#148;), to which this Release is an
exhibit, in consideration for and as condition precedent to the Company&#146;s obligation to provide separation benefits to Employee pursuant to the Employment Agreement and which Employee is otherwise not entitled to receive. Certain terms if they
are not defined in this Release shall have the meaning provided to them in the Employment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In order for this
Release to become effective, Employee must deliver to the Company a properly signed and dated Release on or after Employee&#146;s Termination Date and before <B><U>4:00 pm PST on [DATE]</U></B><B> </B>or else it will be irrevocably determined that
Employee has decided to not execute this Release and this Release shall be null and void with no force or effect. This Release will become effective only if it has been timely executed by the Employee and the revocation period has expired without
revocation by Employee as set forth in Section&nbsp;5(a) below (such effective date of this Release, if any, is the &#147;<U>Effective Date</U>&#148;). By signing below and timely delivering a signed Release to the Company, Employee acknowledges and
agrees to each of the following terms and conditions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">1. <B><U>RECITALS</U></B>. This Release is made with reference to the following
facts: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Employee and Company are parties to the Employment Agreement which provides that Employee must execute a general
release of all claims and covenant not to sue and deliver it to the Company in order to be eligible for certain separation benefits from the Company as specified under the Employment Agreement. This Release is the separation agreement and general
release and covenant not to sue required by the Employment Agreement. If this Release does not become effective by its own terms, then Employee shall receive none of the separation benefits to be provided under the Employment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">2. <B><U>QUALIFYING TERMINATION OF EMPLOYMENT</U></B>. Employee and Company acknowledge and agree that the Employee&#146;s employment with the
Company was terminated [by the Company without Cause] [by Employee for Good Reason] (a &#147;<U>Qualifying Termination</U>&#148;) [as a result of Employee&#146;s Death] [as a result of Employee&#146;s Disability]<SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> as of the close of business on [DATE] (the &#147;<U>Termination Date</U>&#148;), without regard to whether Employee signs this Release or agrees to the following terms and conditions, and that such
termination was treated as a Qualifying Termination [during the Change in Control Period] [outside of the Change in Control Period]<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> by the Company. As of the Termination Date, it is mutually
agreed that Employee is no longer [an </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">NTD: To be specified at the time of termination. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">NTD: To be specified at the time of termination.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
employee] [or director] of the Company and no longer holds any positions or offices with the Company [except for his membership on the Company&#146;s Board].<SUP
STYLE="font-size:75%; vertical-align:top">3</SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">3. <B><U>SEPARATION BENEFITS</U></B>. In consideration for Employee&#146;s general
release of all claims set forth in Section&nbsp;5 below and Employee&#146;s other obligations under this Release and in satisfaction of all of the Company&#146;s obligations to Employee and further provided that: (i)&nbsp;this Release is signed by
Employee and delivered to the Company on or before [DATE], (ii) this Release is not revoked by Employee under Section&nbsp;5 below and therefore becomes effective on or before [DATE], and (iii)&nbsp;Employee remains in continuing material compliance
with all of the terms of this Release and the Employment Agreement, then the Company agrees to provide (and continue to provide) the separation benefits specified in Section&nbsp;4(a) below to Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event that the Company believes Employee is not in continuing material compliance with the terms of this Release, then
the Company shall provide Employee with written notice of the same and, without limiting its other possible actions, the Company shall immediately terminate any and all such separation payments and benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">4. <B><U>PAYMENTS, BENEFITS AND TAXES</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">a. <U>Separation Benefits</U>. The Company will provide to Employee the payments and benefits specified in [Section 4(a)(i)]
[Section 4(a)(ii)] [Section 4(a)(iii)]<SUP STYLE="font-size:75%; vertical-align:top">4</SUP> of the Employment Agreement, subject to Section&nbsp;5 of the Employment Agreement. Subject to Section&nbsp;4(b) below, such payments and benefits will be
provided to Employee at the times specified in the Employment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">b. <U>Taxes</U>. Any tax obligations of Employee
and tax liability therefor, including without limitation any penalties or interest based upon such tax obligations, that arise from the benefits and payments made to Employee shall be Employee&#146;s sole responsibility and liability. All payments
or benefits made under this Release to Employee shall be subject to applicable tax withholding laws and regulations and Employee shall be required to timely and fully satisfy any such withholding as a condition of receipt of any payments or
benefits. The terms of Sections 5, 13 and 14 of the Employment Agreement are also applicable to this Release and to all payments and benefits provided hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">c. <U>WARN Payments</U>. The payments to Employee hereunder shall be considered as including any and all payments by the
Company that could or in fact become payable in connection with the Employee&#146;s termination of employment pursuant to any applicable legal requirements, including, without limitation, the Worker Adjustment and Retraining Notification Act (the
&#147;<U>WARN</U>&#148; Act), California Labor Code sections 1400-1408, or any other similar foreign, federal or state law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">5.
<B><U>EMPLOYEE&#146;S PROMISES</U></B>. In consideration for the promises and payments contained in the Employment Agreement, Employee agrees as follows: </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">NTD: To be specified at the time of termination. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">4</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="justify">NTD: To be specified at the time of termination. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">a. Employee hereby covenants not to sue and also waives, releases and
forever discharges the Company and its divisions, subsidiaries, officers, directors, agents, employees, stockholders, affiliates, attorneys, predecessors and successors from any and all claims, causes of action, damages or costs of any type and
liabilities of whatever kind or nature, in law or in equity, that Employee has ever had or may have as of the Effective Date (whether known or not known) (collectively, &#147;<U>Claims</U>&#148;). This waiver and release includes, but is not limited
to, claims, causes of action, damages or costs arising under or in relation to Company&#146;s employee handbook and personnel policies, or any oral or written representations or statements made by officers, directors, employees or agents of Company,
and also including but not limited to Claims based on and/or arising under any state or federal law regulating wages, hours, compensation or employment, or any claim for breach of contract or breach of the implied covenant of good faith and fair
dealing, or any claim for wrongful termination, or any discrimination claim on the basis of race, sex, sexual orientation, gender, age, religion, marital status, national origin, physical or mental disability, medical condition, or under Title VII
of the Civil Rights Act of 1964, as amended, The Americans with Disabilities Act, The Family Medical Leave Act, The Equal Pay Act, The Employee Retirement Income Security Act, The Fair Labor Standards Act, The California Fair Employment and Housing
Act, The California Constitution, The California Government Code, The California Labor Code, The Industrial Welfare Commission&#146;s Orders, The Worker Adjustment and Retraining Notification Act, the California Labor Code, the California Family
Rights Act, Act, the California Wage Orders, the California Private Attorneys General Act of 2004, the California Wage Orders, and the California Business and Professions Code Section&nbsp;17200, et seq., and any and all other Claims Employee may
have under any other federal, state or local Constitution, Statute, Ordinance and/or Regulation; and all other Claims arising under common law including but not limited to tort, express and/or implied contract and/or quasi-contract, arising out of
or, in any way, related to Employee&#146;s previous relationship with the Company as an employee, consultant and/or director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, Employee expressly acknowledges, understands and agrees that this Release includes a waiver and release of all claims which
Employee has or may have under the Older Workers Benefit Protection Act and the Age Discrimination in Employment Act of 1967, as amended, 29 U.S.C. &#167;621, et seq. (&#147;<U>ADEA</U>&#148;). The following terms and conditions apply to and are
part of the waiver and release of ADEA claims under this Release: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(1) Employee was advised and encouraged to consult with
an attorney before signing this Release; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(2) Employee was granted <FONT STYLE="white-space:nowrap">twenty-one</FONT>
(21)&nbsp;days after Employee was presented with this Release to decide whether or not to sign this Release. Employee understands and agrees that any modification of this Release, whether material or immaterial, does not restart the running of this <FONT
STYLE="white-space:nowrap">21-day</FONT> consideration period; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(3) Employee will have the right to revoke the waiver and
release of claims under the ADEA within seven (7)&nbsp;days of Employee signing this Release, and this Release shall not become effective and enforceable until that revocation period has expired without such revocation; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(4) Employee hereby acknowledges and agrees that Employee is knowingly and
voluntarily waiving and releasing Employee&#146;s rights and claims, including under the ADEA, in exchange for consideration (something of value) in addition to anything of value to which Employee is already entitled; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(5) Nothing in this Release prevents or precludes Employee from challenging or seeking a determination in good faith of the
validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs from doing so, unless specifically authorized by federal law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(6) Therefore, Employee may unilaterally revoke this Release at any time up to seven (7)&nbsp;calendar days following
Employee&#146;s execution of the Release, and this Release shall not become effective or enforceable until the revocation period has expired which is at 12:00:01 a.m. PST on the eighth day following Employee&#146;s execution of this Release. If
Employee elects to revoke this Release, such revocation must be in writing addressed to the General Counsel of the Company and received by the Company via facsimile or email no later than the end of the seventh day after Employee signed this
Release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">b. The waiver and release set forth in this Section&nbsp;5 applies to claims of which Employee does not
currently have knowledge and Employee specifically waives the benefit of the provisions of Section&nbsp;1542 of the Civil Code of the State of California which reads as follows: &#147;<I>A general release does not extend to claims that the creditor
or releasing party does not know or suspect to exist in his or her favor at the time of executing the release and that if known by him or her, would have materially affected his or her settlement with the debtor or released party</I>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">c. Employee agrees that the Company has paid to Employee all salary and vacation which had accrued as of the Termination Date
and that these payments represent all such monies due to Employee through the Termination Date. In light of the payment by the Company of all wages due, or to become due to Employee, California Labor Code Section&nbsp;206.5 is not applicable. That
section provides in pertinent part as follows: &#147;<I>No employer shall require the execution of any release of any claim or right on account of wages due, or to become due, or made as an advance on wages to be earned, unless payment of such wages
has been made</I>.&#148; Except with respect to any &#147;Excluded Claims&#148; (specified in Section&nbsp;5(d) below), Employee further represents and warrants to the Company that, as of the Effective Date, the payments set forth in
Section&nbsp;4(a) above constitute all payments or obligations owed by the Company to Employee in connection with any employment, severance, retention, or a change in control plan or arrangement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">d. Notwithstanding anything to the contrary, the Employee is not waiving any Claims Employee may have with respect to any of
the following matters: (i)&nbsp;any rights that Employee may have to file a charge, testify, assist, or cooperate with the U.S. Equal Employment Opportunity Commission or another fair employment practices governmental agency; (ii)&nbsp;claims for
indemnification from the Company, including without limitation under any contractual arrangements to which Employee is party with the Company, the Company&#146;s charter and bylaws and in accordance with Section&nbsp;2802 of the California Labor
Code; (iii)&nbsp;claims to unemployment compensation benefits or workers compensation benefits; (iv)&nbsp;claims under the Fair Labor Standards Act; (v)&nbsp;health insurance benefits under the Consolidated Omnibus Budget Reconciliation Act (COBRA);
(vi) claims with regard to vested benefits under a retirement plan </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
governed by the ERISA; (vii)&nbsp;any events, occurrences, acts or omissions which occur after the Effective Date; (viii)&nbsp;claims under any directors and officers liability insurance policy;
(ix)&nbsp;claims for any vested equity; (x)&nbsp;claims for breach of this Release; or (xi)&nbsp;claims that may not be released as a matter of applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">e. Employee has not suffered nor aggravated any known
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">on-the-job</FONT></FONT> injuries for which Employee has not already filed a Workers&#146; Compensation claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">f. Employee agrees that nothing in this Release shall be construed as an admission of liability of any kind by Company to
Employee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">g. In the event that Employee breaches or threatens to breach any of the provisions contained in this
Section&nbsp;5, Employee acknowledges that such breach or threatened breach shall cause irreparable harm, entitling the Company, at its option, to seek immediate injunctive relief, from a court of competent jurisdiction without waiver of any other
rights or remedies from a court of law or equity and without posting of bond. In addition, should the Company prevail before a court of competent jurisdiction or arbitration, Employee agrees to reimburse the Company for all expenses incurred,
including reasonable attorneys&#146; fees. Should Employee attempt to challenge the enforceability of any provision of this Release, Employee shall initially tender to the Company, by certified check, all amounts received pursuant to this Release
and shall not be entitled to receive any further payment or benefit hereunder or under the Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">h. Employee
reaffirms that Employee will continue to be bound by, and will continue to comply with, all of the terms and conditions and covenants in Sections 5, 7 through 15 of the Employment Agreement and also all terms and conditions of the Confidentiality
Agreement (as such term is defined in the Employment Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">i. Employee represents and warrants to the Company that,
as of the Effective Date, Employee has no outstanding agreement or obligation that is in conflict with any of the provisions of this Release, or that would preclude Employee from complying with the provisions hereof, and further certifies that
Employee will not enter into any such conflicting agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">j. Employee will not, at any time following the Termination
Date, make (or direct anyone else to make) any disparaging statements (oral or written) about the Company, or any of its affiliated entities, officers, directors, employees, stockholders, representatives or agents, or any of the Company&#146;s
products or services or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">work-in-progress,</FONT></FONT> that are harmful to their businesses, business reputations or personal reputations. The Company will not in any authorized
corporate communication, and will instruct the members of the Board to not, make (or direct anyone else to make) any disparaging statements (oral or written) about the Employee, that are harmful to the Employee&#146;s businesses, business reputation
or personal reputation. Notwithstanding this Section&nbsp;5(j), nothing herein shall prohibit any party from providing truthful testimony in connection with a governmental investigation or legal proceeding or from reporting a suspected violation of
law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">6. <B><U>MISCELLANEOUS</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">a. This Release shall be deemed to have been executed and delivered within the State of California, and the rights and
obligations of the Company and Employee shall be construed and enforced in accordance with, and governed by, the laws of the State of California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">b. This Release, and the surviving provisions of the Employment Agreement, are the entire agreement with respect to the
subject matter hereof and supersedes all prior and contemporaneous oral and written agreements and discussions. This Release may be amended only by an agreement in a writing signed by Employee and an authorized representative of the Company and
which expressly references that this Release is being amended. Employees agree that the release set forth in Section&nbsp;5 above shall be and remain in effect in all respects as a complete general release as to the matters released. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">c. This Release is binding upon and shall inure to the benefit of the Company, its respective agents, employees,
representatives, officers, directors, divisions, subsidiaries, affiliates, any parent company, assigns, heirs, partners, successors in interest and stockholders, including any successor company of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">d. Employee agrees that Employee has read this Release and has had the opportunity to ask questions, seek counsel and time to
consider the terms of the Release. Employee has entered into this Release freely and voluntarily. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">e. Employee understands
and agrees that Employee is solely responsible for any and all liability under federal and state tax laws arising from the payments made under the Agreements. Employee understands that the released parties make no warranty concerning the treatment
of any funds paid hereunder under said laws, and Employee has not relied upon any such warranties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">f. Employee declares,
covenants and agrees that Employee has not assigned heretofore, and has not and will not hereafter sue, any of the released parties before any court or governmental agency, commission, division or department, whether state, federal or local, upon
any claim, demand or cause of action released herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">g. If any provision of this Release or application thereof is held
invalid, the invalidity shall not affect other provisions or applications of the Release which can be given effect without the invalid provision or application. To this end, the provisions of this Release are severable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Jeffrey Stibel (&#147;<U>Employee</U>&#148;) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Date: <U>&#8195;&#8195;&#8195;&#8195;&#8195;</U></P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EXHIBIT E </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONFIDENTIAL INFORMATION AND EMPLOYEE INVENTION ASSIGNMENT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">[***] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d843790dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>LegalZoom Announces Leadership Transition </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><I>Current Chairman Jeffrey Stibel to become next CEO </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><I>John Murphy named Lead Independent Director </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">MOUNTAIN VIEW,
Calif., July&nbsp;9, 2024 &#150; LegalZoom.com, Inc. (Nasdaq: LZ) today announced that the Company&#146;s current Chairman of the Board of Directors, Jeffrey Stibel, has been named LegalZoom&#146;s next CEO, effective immediately. LegalZoom has also
appointed John Murphy as the Lead Independent Director of the Board. As part of this transition, current Chief Executive Officer Dan Wernikoff will be departing the Company, including resigning from the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The Board and Mr.&nbsp;Wernikoff decided that now is the right time for this transition, as the Company increases its focus on shifting towards subscription-based
revenue to drive long-term profitable growth. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">&#147;The Board identified Jeff as the ideal CEO to lead LegalZoom&#146;s next chapter,&#148; said Mr.&nbsp;Murphy.
&#147;He is a seasoned executive who has been a deeply involved member of the Board for nearly a decade, including serving in a leadership position as Chairman since 2018. Jeff possesses extensive knowledge of the Company&#146;s product offerings,
technology infrastructure, and attorney network, as well as the competitive landscape and customer segment. He also brings ideal experience to the role, having been an executive officer of numerous technology services companies where he successfully
scaled and enhanced profitability for subscription technology offerings &#150; an increasingly key strategic focus area for LegalZoom. Finally, as one of our largest individual investors, Jeff will be closely aligned with all our shareholders as he
focuses on creating long term value.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Mr.&nbsp;Stibel joined the Board of LegalZoom in 2014, and over the course of his career has established an extensive
track record as both a successful investor and operating executive, with a focus on subscription businesses serving entrepreneurs. He has been a partner of Bryant Stibel&nbsp;&amp; Company, an investment and strategic advisory platform, since 2013.
Mr.&nbsp;Stibel served as the Vice Chairman of Dun&nbsp;&amp; Bradstreet until the company was taken private in 2017 and was Chairman and CEO of a predecessor company acquired by Dun&nbsp;&amp; Bradstreet, where he helped to grow the small business
customer base nearly 500% to over two million subscribers. Prior to that, Mr.&nbsp;Stibel was President and CEO of Web.com, Inc., where he grew the business into one of the largest web services providers in the world until its sale, which resulted
in a roughly 200% increase in shareholder value during his tenure. In his capacity as board member, investor and advisor while at Bryant Stibel, he has helped to grow subscription companies such as MyFitnessPal, Life360, McAfee and TeamViewer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">&#147;I am thrilled to be taking on this new challenge across a $51&nbsp;billion serviceable addressable market with our amazing team,&#148; said Mr.&nbsp;Stibel.
&#147;Given our leading brand position and the progress we have made shifting our business towards subscription revenue, I believe that LegalZoom is well positioned to disrupt the legal and compliance services industry focused on serving small
businesses and consumers. I especially want to thank Dan for his strong leadership and everything he has given to the business during his time as CEO. The team and I look forward to having more updates to share with investors and all our
stakeholders on our second quarter earnings call.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Mr.&nbsp;Wernikoff took over as CEO in October of 2019. He led the company through <FONT
STYLE="white-space:nowrap">COVID-19,</FONT> took it public in June 2021, and after building a world-class team across competencies, drove multiple new product launches. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Mr.&nbsp;Murphy continued, &#147;The entire Board would like to thank Dan for his contributions to LegalZoom, and we wish him further success in the future. Dan built a
strong foundation for growth, a talented and committed global organization and instilled a performance-based culture that will help ensure LegalZoom is well-positioned for its next phase.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">For the second quarter ending June&nbsp;30, 2024, LegalZoom continues to expect revenue in the range of $172&nbsp;million to $176&nbsp;million and Adjusted EBITDA in
the range of $25&nbsp;million to $27&nbsp;million. For the full year ending December&nbsp;31, 2024, LegalZoom is reiterating that Adjusted EBITDA is expected to be in the range of $135&nbsp;million to $145&nbsp;million. The Company is reducing its
revenue expectation for the full year to a range of $675&nbsp;million to $685&nbsp;million and its free cash flow expectation for the full year to a range of $75&nbsp;million to $85&nbsp;million. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Forward-Looking Statements </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">This press release contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking
statements contained in Section&nbsp;27A of the Securities Act of 1933, as amended and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release may
be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;expects,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;could,&#148;
&#147;intends,&#148; &#147;targets,&#148; &#147;projects,&#148; &#147;contemplates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;forecasts,&#148; &#147;predicts,&#148; &#147;potential&#148; or &#147;continue&#148; or the negative of
these terms or other similar expressions. Forward-looking statements contained in this press release include, but are not limited to, statements regarding our leadership transitions, our strategy and our guidance for the second quarter ended
June&nbsp;30, 2024 and the full year ending December&nbsp;31, 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">The forward-looking statements in this press release are only predictions. We have based these
forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known
and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking
statements, including but not limited to the following: our dependence on business formations and fluctuations or declines in the number of business formations may adversely affect our business; our dependence on customers expanding the use of our
platform, including converting our transactional customers to subscribers and our subscribers renewing their subscriptions with us; the impact of macroeconomic challenges on our business, including as a result of inflation, global conflict, supply
chain issues and recessionary concerns; our ability to sustain our revenue growth rate and remain profitable in the future; our ability to provide high-quality products and services, customer care and customer experience; our ability to continue to
innovate and provide a platform that is useful to our customers and that meets our customers&#146; expectations; the competitive legal solutions market; our dependence on our brand and reputation; our ability to maintain and expand strategic
relationships with third parties; our ability to hire and retain top talent and motivate our employees; risks and costs associated with complex and evolving laws and regulations; our ability to maintain effective internal control over financial
reporting; and other factors discussed in the section titled &#147;Risk Factors&#148; included in our Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarterly period ended March&nbsp;31, 2024 filed with the Securities
and Exchange Commission, or SEC, on May&nbsp;7, 2024, as well as those factors in our subsequent filings with the SEC. The forward-looking statements in this press release are based upon information available to us as of the date of this press
release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or
review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. You should read this press release with the understanding that our actual
future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan
to publicly update or revise any forward-looking statements contained in this press release, whether as a result of any new information, future events or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>About <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">This press release includes references to Adjusted EBITDA and Free Cash Flow, each a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure. To supplement
our unaudited condensed consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles in the United States, or GAAP, we use certain <FONT STYLE="white-space:nowrap">non-GAAP</FONT>
financial measures, as described below, to understand and evaluate our core operating performance. These <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures, which may be different from similarly titled measures used by other
companies, are presented to enhance investors&#146; overall understanding of our financial performance and liquidity and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with
GAAP. We believe that these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures provide useful information about our financial performance and liquidity, enhance the overall understanding of our past performance and future prospects
and allow for greater transparency with respect to important measures used by our management for financial and operational decision-making. We are presenting these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measures to assist investors in
seeing our financial performance using a management view and because we believe that these measures provide an additional tool for investors to use in comparing our core financial performance over multiple periods with other companies in our
industry. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We define Adjusted EBITDA as Net income (loss) adjusted to exclude interest expense, interest income, provision for
(benefit from) income taxes, depreciation and amortization, other expense (income), net, stock-based compensation, impairment of goodwill, long-lived and other assets, legal expenses, restructuring expenses, transaction-related expenses and certain
other <FONT STYLE="white-space:nowrap">non-recurring</FONT> income and expenses from time to time. Our Adjusted EBITDA financial measure differs from GAAP in that it excludes certain items of income and expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Adjusted EBITDA is one of the primary performance measures used by our management and our board of directors to understand and evaluate our financial performance and
operating trends, including <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> comparisons, prepare and approve our annual budget, develop short and long-term operational plans and determine appropriate
compensation plans for our employees. Accordingly, we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our results of operations in the same manner as our management team and board of
directors. In assessing our performance, we exclude certain expenses that we believe are not comparable period over period or that we believe are not indicative of our underlying operating performance. Adjusted EBITDA should not be considered in
isolation of, or as an alternative to, measures prepared and presented in accordance with GAAP. There are a number of limitations related to the use of Adjusted EBITDA rather than net income (loss), which is the nearest GAAP equivalent of Adjusted
EBITDA. Some of these limitations include that the <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">may be calculated differently by other companies in our industry, limiting its usefulness as a comparative measure;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">does not reflect our capital expenditures, future requirements for capital expenditures or contractual commitments;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">excludes depreciation and amortization and, although these are <FONT STYLE="white-space:nowrap">non-cash</FONT> expenses,
the assets being depreciated may be replaced in the future; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">does not reflect changes in, or cash requirements for, our working capital needs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">excludes stock-based compensation expense, which has been, and will continue to be, a significant recurring expense for our
business and an important part of our compensation strategy; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:ARIAL; font-size:10pt">does not reflect certain other expenses that we do not consider representative of our underlying operating performance, but
that reduce cash available to us. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">Free cash flow is a liquidity measure used by management in evaluating the cash generated by our operations
after purchases of property and equipment including capitalized <FONT STYLE="white-space:nowrap">internal-use</FONT> software. We consider Free cash flow to be an important measure because it provides useful information to management and investors
about the amount of cash generated by our business that can be used for strategic opportunities, including investing in our business and strengthening our balance sheet. Once our business needs and obligations are met, cash can be used to maintain a
strong balance sheet and invest in future growth. The usefulness of Free cash flow as an analytical tool has limitations because it excludes certain items that are settled in cash, does not represent residual cash flow available for discretionary
expenses, does not reflect our future contractual commitments, and may be calculated differently by other companies in our industry. Accordingly, it should not be considered in isolation or as a substitute for analysis of other GAAP financial
measures, such as net cash used in or provided by operating activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">We are not providing a reconciliation for our
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> outlook on a forward-looking basis, as we are unable to provide a meaningful calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is
due to the inherent difficulty of forecasting the timing or amount of various items that would impact the most directly comparable forward-looking GAAP financial measure that have not yet occurred, are out of LegalZoom&#146;s control and/or cannot
be reasonably predicted. Forward-looking <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures provided without the most directly comparable GAAP financial measures may vary materially from the corresponding GAAP financial measures.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>About LegalZoom </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">LegalZoom is the leading online platform for business formation in the United States. Driven by a mission to unleash entrepreneurship, LegalZoom delivers comprehensive
legal, tax and compliance products and expertise for small business owners through <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">easy-to-use</FONT></FONT> technology. From free business formations to business management solutions
and professional advisory services, LegalZoom supports millions of small business owners and their families throughout the entrepreneurial journey. Founded on the belief that everyone should have affordable access to legal and financial expertise,
LegalZoom empowers entrepreneurs to make their dream a reality. To learn more about LegalZoom, visit<B>&nbsp;<U>www.legalzoom.com</U></B>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Investor Contact
</U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">investor@legalzoom.com </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL"><B><U>Media Contact </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL">LegalZoom@longacresquare.com </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>lz-20240708.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 7/10/2024 1:47:17 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:lz="http://leg.com/20240708"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://leg.com/20240708"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lz-20240708_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lz-20240708_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>lz-20240708_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 7/10/2024 1:47:17 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lz-20240708_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 7/10/2024 1:47:17 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="lz-20240708.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm140517077110336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001286139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  08,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LegalZoom.com, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4752856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">954 Villa Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Mountain View<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(323)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">962-8600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LZ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MO@>0X?L%2:DB&RHR1G[T6K"4DA1ZJM=4H<1'>W_<M5\5C6SES??Q0M;678/
MXQO&47E]@/MRF;F[7;BFR8J=W*0U"#U/YK>3/S"FRN2#LTS^+F9J97/T"13,
MVE9@2I/:;7^#X,E"<X^.E_:H_D3M%S41; E"7NL*#%L5I]^B862:GS@7TL#Y
M-;]<,PJ3P+X SY=2FH^&/<26_X,8_PM02P,$%     @ NH[I6)^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ NH[I6 =!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " "ZCNE8U]5RSN\    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " "ZCNE8F5R<(Q &  "<)P  $P
M        @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +J.
MZ5@0S(A<3@0  (\0   8              " @0X(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " "ZCNE8GZ ;\+$"  #B#   #0
M        @ &2#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +J.Z5B7BKL<
MP    !,"   +              "  6X/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( +J.Z5@<.&7J/P$  #P"   /              "  5<0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " "ZCNE8)!Z;HJT   #X 0  &@
M    @ '#$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" "ZCNE899!YDAD!  #/ P  $P              @ &H$@  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  #R$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d843790d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d843790d8k.htm">d843790d8k.htm</File>
    <File>lz-20240708.xsd</File>
    <File>lz-20240708_lab.xml</File>
    <File>lz-20240708_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d843790d8k.htm": {
   "nsprefix": "lz",
   "nsuri": "http://leg.com/20240708",
   "dts": {
    "inline": {
     "local": [
      "d843790d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "lz-20240708.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "lz-20240708_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lz-20240708_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-07-08_to_2024-07-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d843790d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-07-08_to_2024-07-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d843790d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://leg.com//20240708/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-176824-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-176824-xbrl.zip
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MY%^+\Q[/MQ5>^^S!]IW_2/]!45"*J38P6[?5;2]#TE?K2VXBPE6#.,SX? Z
M :7/'79^+ZPHE+>"78W I@BU\S6')56@-T."[Q3(L\#J;9CGWDIJ+<VE_?V[
M@TY[_TBQ&^$(?^*YL1M%:4$G0L/)3H&%:$-+\MVHPW#<(QF] ^C;[>SN%/.1
M#X[U/GI OL^XM<>&=_O OX=[G?K!7JNU7O'N)8A[Z87LU/<=X%I@M<?D<;?C
ME_X(!@%BN$O*XP;,?#1R7F-RA+E;=RQL-D"#PSYR%9H*S&LV]VEJH:OX#.SR
M1%A?J&K'?3#>?B Q(!]Z]VPH'.\.J88/D9BK19-JW20>;"0=U"A2,8G=?S90
M/?28DM/(";DKO$@Y,Z9 (M5H1BN8%[PAX$O'$J::&*3U@ CF"1AW9_&S$;CS
MWAV^AXZ'Q!!5L:H2@GT0K@C HERX\&Y$"07%3AN=AM[73K^4X_8>&I)L->1(
MXHPT]B@&.7-!T%I.0651?-#]_FBA_2M3M;\&,@2J8F(@<DWLIQ[M00X]SQER
MH&@(_)=5QUW$]^%^MWM4U,8K_(+Y>)WE2<L>K:GG>MHJ)P8W@(PL<IB?J>!?
M1\ NW4[/,/1<S1Q+Y=7V/CO[\9IU=EL-&+A)3/W*OZOY=P :VP)LN^-/H.Y
MYSE/Q[R];XEY4\3 U!HS1<Y=:0?:75YO=V)3D#)YKALD9O&5LW6ZK8:><2?C
M?+U*P]:DX7,@4)-C]S3UO*&Y#B  >X +O;94['U+4K&210&#=2N#PICU5]F
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MQQPOL(L^30"#5*3M"KU%C[JM=O7+#LAW"/X-;3FV.5I'5.T,^;*$*!JIFJ[
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MQ+N@&A?$WUI74<AGHL,X8X8<[45AG!FP>*1$7..JBOLXC*.<"U>Z;F +#F(
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MC4UG(,;83&.V]< T,XFYKNCM/+^CD6\,7EB.PS18&')KKCVXW=IR>_ -V5[
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MN:?TQ'#Y-+TXW9"W^+7I:;+LFPR8>R4!\W%SZ-DS^#P)I\[)_P%02P,$%
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M.6W6PLBA<!EG"X/45U^U1W:TJ;M%E\=$MP,!-] R+1;4B8^V7_+_EG$D4:Z
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MNCC@S:0BW5E#P>?M_)^\QW]%F# !G8)*B4ETF-%<DV]O*^?'1PH*7C_5Y@O
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MJ>\.R&T_&UN52FFZ\X/_/E;*]=;E+88QP 7@%O*5K!V.D5MM.+]?B8/6G,1
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M/#B7O)1%M*":@"_RAWXD!1W](F.@SI3NK\=$=0%>I?J5.1/@)HFSA0AP]/3
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M!EZ1IM.FCZ*IK4N=&O;W1<PL(K@0\\^H_KY1%96T6\Q8IT:VBJ//I:$Q#6H
MG%^V[HK-LX+ODCI#2>K,-;@&X!ZH5.4+G3)VZ0+*!/-D>-@,S2):\1*S;'5*
M4T.AJN &&[,O@ PO>.7:"P1CII*L4E'6MZL5R!=VG%NK? YG!"6K@&DG#3&D
MEF]8RC6W*21X)J9?I^OGJO.07,PSO(IQ]Y:Y"V&%+ M;,,DNTV$R S@-)5A5
MMQ_*EWX8\O=*(8RIC*M9BR4V65N4;T<?*E\Q?__ 63V!'D?P9Y(^UW4_QE@I
M8$IJ3;U4L4728KY6@NF='\ G7_H/=LYD7UH1OF2^<Y&"\XBJI6KH4+LWN\=@
M[@BA?I1D>0M;.&FJZ%4#]F,-_@&VIR18A\5^'KY]=7HP>CX<[%QF(YM"X--@
M"O*%V#=X&S(-V&PIZ8YO,:N;*^7DLZHH1$Y/S@Y0%C*M>C@$,F::=J*GP23G
M5.X240Z2$N(/B;/5OLGXV5F7>#+60% <=,H,ND-5*SBI) 3)&D4J^]!2+?0P
M$2B&Z\"+.SZFD10Z=P%_VOD0GD[4O*API7ND-;@)EL]*FVP@!:Z^B>#)9]]M
M.J. =A&.OVIF,X*LYX21F9?Q)3-3P+J1FW*-SG77:$NR"Q*P^V<QD>2 R1%D
M^9\-PL88?.+K9S-"$RS$:PW&91*(K)C]1H*T07=@H6<]?D[>$UST2@AJX\>0
MZ6MOW)D2?C&P"9PV62MKS<5L;C^",2>'*"BCM,O"!XXCD^!5(1T*5P++211'
M*0@JM/CN ZOW21]?F.5BL2?=O1:U'O]2V@PA"([(YK <#X\OW/W+L42K+26+
M,1:DIW&QDJ*(@@*_JA\%"GG.F@\13^EL+-A%K/?@]#'=W\1KC^>A2C)G9*.I
M(U$@V7:RNX8#L0/)X\=7I57KL0)59,7';H<\<554IJORI,@3VBH3R$?:>XI%
M:$\ X]\899-,[_:QDV4_R>I2D%^M X'!Q&PY:<HJ]=Y$6ANV(?V !YN<5;IM
MDC':B<8*+(G9B';'XD5%)<S@\7O1&<]!E?758%&1M6WB].+&FA"L=[9<CX56
M.C6HY,K ..9839WF28M/<8PG5+HI(Z#E(IV^'],$N5%5Y>*</E&F>R5'+KR.
MQ1U4F#1L6SIOO&%;[:8JE@HOJV"J1*K;5QD73F]BNA5!P>4R='4H::L+T&$Y
M)M@K&A9Z+$(>?((*L-G0'[=+Y$.0AV)9JY233X5RW]D0T/[&&E6'LC:-1ON:
MYH(%/<MP^4"&0/Z& \5-B]QRIG,%^BL>F6GWBT>WOXN9NOT^)NH!8MX;]@BL
M K_9CETP+Z(AT5;#G3 #6ZQV88O.@+5_SNF*@$=P8-8D_<*<'XF6\4O#9^*9
M*V9CC]7"Z *6:Y5E(;$5GMNT9)YA6_YI9N!-^/;W^L^]J#7^L9=H4Y J/V@Z
M'/#6+N/W:;1C<73X3604)/)76 '\\\C@CZF)!N4N'01\)T",4]BKJ7T=;,#E
M,[JK;;5!PHJTOW"AMV!!P](O-<)<OZL=1Z":\Z01ETEZT]&_/]_*QF  ;.PN
MO&&.R;9Q8&S;EN]HSA#(FPYA5EI*/2X1$( JS+!1H'N&[%.NQ?Z^@YE :# H
MAV?SR,.!X;-."1;:Y!+H4?HZ(\MWROLF)#]F#8G21\A\OZS N*A[SVJU<JA;
MUH[23!UKU]7)NI7*V_ES-+9. ^H21!<9/A!B]I9J;PQCD3KB"#\]KH3E9R@_
MG-5EP9RGK0BN'Z7+J*N24:"($*:J8'CJ-$T3P370BV F15D+@R\GR> T76;%
MPC58TE[OMRC-9T=IGAI2DU].SK"8\>#-\=M?[QB+R7FG6YO@=44'F&+4E(^Q
M_-<^4Y-@Z'IRP@Y2[X!-<,)\DHL01]!F7E!NMD/2=05S^7TJ.,:Q80K_]F>N
M[\!63/RM<.M6-7#E7%JJ^THO6G?M>&S2?3F&7Y6U%28Q",9D6#(D#,8&D)3N
MH1I,"5:^,,U_#9D4W+.@E?,4\?BDGNE>D!(P^THV(K$.J>%08R!P&)3#IJ\,
M!6?V=>K4H$:-FVQA*98YS"<@PR\X$)1_U7=(V'# H2N'N[?TW9WH>LQ(DN;D
M<3H3J@H)@SLQ'R'<@Y)\5K89*H*L883G(SN:)DW96]JLRA"(P&O!<V^A*&)K
MGTL&RH8X[X!D3]LLVI.,;U"BGG&N,GA_I>5/#X J+J]$#C@M"_G0K4)5=$0]
M4Z_'4NPMB/5*6_FV-CD=CA]51#@\CM 4PYI7N,US>KHJ=J7=%)X=FJ%GC/I<
M(_9KYAW!I._ )B8] 5+/S<.P;P#@RQD)=Q&S,BM4=A*=I>I]]+\-&C"\#1B&
MFPJ^S'0?H""I ;:J(("/XPL"Y:EN_>*-: 9C%]X>!<Z]?;^LIWA 2EY[T,;(
MI43*2]B4A Y?UYRY&#1'D PZE&42;T(BE:+TJ)1FV5RNS^[4'8'JK'@(U6%B
M6PR0*Y 7)JY ^5\XF;EQ-XEG&Q]-M9\<(,,G$L#(!<2$R =_B4,?^V:#2410
M\#8Q6L;0,O&;L_0.A,]TVB%)IPM0-*B_7#"K=_-MKJ62&Q'7IBX89&M.'7W
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M^>K$=D$B5VBU=%/$:'RH""4''U*'WS1P[<&VCQ3"NY5IB:O*IM#<)N6]&BQ
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M=3#O(UG&5 2\(2 '^&LI707;U '3$AF!8"0Z<'W4+(YG2,^*,07(;FJ)'$3
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M!/U3&!KRSR5; EZ7 2Y %\*%'=M '>IV+A Q3]\4W(A;P1\H"QJ^MZW2> W
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MT8;A0SY;+^4=5VI+_]Z)?!?-?ON"VO,?4$L#!!0    ( +J.Z5BF,P>VL 0
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M.YI:N;:ZT,K].F;GGC'#TW^I9E+EI1U@A:$KY[C$K[HR/1'A-T)5G>@W[#O
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ML'=(KH_8)WN_'[;\"U!+ 0(4 Q0    ( +J.Z5B;.J]8[1L  %&D   .
M          "  0    !D.#0S-SDP9#AK+FAT;5!+ 0(4 Q0    ( +J.Z5@E
MKO9<F&P  ,,! @ 1              "  1D<  !D.#0S-SDP9&5X,3 Q+FAT
M;5!+ 0(4 Q0    ( +J.Z5A9O05.X!D   !:   1              "  >"(
M  !D.#0S-SDP9&5X.3DQ+FAT;5!+ 0(4 Q0    ( +J.Z5AZH:I].P,  "L+
M   /              "  >^B  !L>BTR,#(T,#<P."YX<V102P$"% ,4
M" "ZCNE8-A3X@EL&  "^0P  $P              @ %7I@  ;'HM,C R-# W
M,#A?;&%B+GAM;%!+ 0(4 Q0    ( +J.Z5BF,P>VL 0  &@J   3
M      "  >.L  !L>BTR,#(T,#<P.%]P<F4N>&UL4$L%!@     &  8 >0$
' ,2Q      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d843790d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lz-20240708.xsd" xlink:type="simple"/>
    <context id="duration_2024-07-08_to_2024-07-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001286139</identifier>
        </entity>
        <period>
            <startDate>2024-07-08</startDate>
            <endDate>2024-07-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-351">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-07-08_to_2024-07-08"
      id="Hidden_dei_EntityCentralIndexKey">0001286139</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-362">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-363">2024-07-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-364">LegalZoom.com, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-365">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-366">001-35618</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-367">95-4752856</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-368">954 Villa Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-369">Mountain View</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-370">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-371">94041</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-372">(323)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-373">962-8600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-374">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-375">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-376">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-377">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-378">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-379">LZ</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-380">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-07-08_to_2024-07-08" id="ixv-381">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
